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I. INTRODUCTION 
At the request of concerned residents, the Northampton Board of Health, and the Mayor 
of Northampton, the Community Assessment Program (CAP) of the Massachusetts 
Department of Public Health (MDPH), Bureau of Environmental Health conducted an 
evaluation of available health outcome data for the city of Northampton and the town of 
Easthampton.  This evaluation was initiated due to community concerns about potential 
environmental exposures in the area surrounding the Northampton Regional Landfill on 
Glendale Road in the southwestern part of Northampton, near the border of Easthampton, 
and potential past and current health effects (see Figure 1).  To best address these 
concerns, the CAP focused this investigation on the neighborhoods/census tracts (CTs) in 
closest proximity to the landfill, CT 8222.00 in Northampton and CT 8224.011 in 
Easthampton (see Figure 1), as well as the communities of Northampton and 
Easthampton as a whole.  In addition, the CAP conducted an evaluation of cancer 
incidence within a one-mile radius of the Northampton Regional Landfill. 
At a scoping meeting with Northampton officials in August 2007, it was agreed that 
MDPH would review readily available health outcome data as a service to the 
community.  These health outcomes include cancer, low birthweight, birth defects, 
asthma, childhood blood lead levels, and autism.  It is important to note that this 
evaluation is meant to serve as a screening-level assessment.  Each health outcome 
                                                 
1 In 1990, the U.S. Census Bureau split what was then Easthampton CT 8224 into two census tracts referred 
to as 8224.01and 8224.02.  CT 8224 in 1980 was the Easthampton CT closest to the Northampton Regional 
Landfill, and then in 1990, this area of Easthampton became CT 8224.01.  For this report, MDPH refers to 
CT 8224.01 as the one in closest proximity to the landfill.  For accuracy, it is important to note that the 
population data for the years between 1982 and 1991 reflect the CT 8224 boundaries. 
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evaluated in this report has several risk factors/causes associated with its development.  
The primary purposes of this type of assessment are to evaluate whether any unusual 
patterns emerge when assessing disease incidence in the community, in this case 
particularly in relation to the Northampton Regional Landfill, and/or to generate 
hypotheses for possible future public health investigations. 
II. CANCER INCIDENCE 
This investigation provides a review of the pattern of nine cancer types in each 
community as well as in each of the neighborhoods/ CTs mentioned previously and 
compares the incidence of these cancers with the cancer experience of the state of 
Massachusetts as a whole.  Cancer incidence data were obtained from the Massachusetts 
Cancer Registry (MCR) for the years 1982-2004.  The MCR began collecting population-
based cancer incidence data in January of 1982.  The 1982-2004 time period was 
evaluated by assessing four time periods within the 23-year period: 1982-1986, 1987-
1991, 1992-1996 and 1997-20042; this allowed for consideration of possible patterns or 
trends as compared to the statewide cancer experience.  The nine cancer types selected 
for this evaluation were based on contaminants of concern at the Northampton Regional 
Landfill and/or resident concern over suspected elevations of some cancer types.   
In addition to calculating cancer incidence rates, a qualitative analysis of the geographic 
distribution of individuals diagnosed with each of the nine types of cancer was conducted 
by mapping their residence at time of diagnosis.  This was done to assess whether the 
                                                 
2 The first three time periods constitute five-year periods while the last time period constitutes an eight -
year period.  Because the City of Northampton hired a consulting firm to conduct similar analyses, MDPH 
chose similar time periods for clarity.  For this reason, the numbers of reported cancer diagnoses, as well as 
the numbers of expected diagnoses based on statewide cancer incidence data, most likely will be higher in 
the latest time period compared to the earlier time periods. 
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geographic patterns of any particular type of cancer in either community or in the census 
tracts of interest appeared unusual.  Available risk factor information from the MCR 
related to age and gender, as well as other factors related to the development of cancer 
such as smoking and occupation, was reviewed in those instances where the incidence 
rate of a particular cancer type was higher than expected.  This information was evaluated 
to compare known or established risk factor patterns, as reported in the medical and 
epidemiological literature for particular cancer types, to risk factor information for 
individuals diagnosed in Northampton or Easthampton, to assess whether any unexpected 
patterns existed among individuals diagnosed in Northampton or Easthampton.  Finally, a 
qualitative analysis of cancer incidence within a one-mile radius of the landfill was 
conducted for the period 1982 to the present3.  This included evaluating the types of 
cancer diagnosed, their spatial and temporal distribution, and available risk factor 
information. 
A. Methods for Analyzing Cancer Incidence 
1.  Case Identification/Definition 
Cancer incidence data (i.e., reports of new cancer diagnoses) for Northampton and 
Easthampton for the years 1982-2004 were obtained from the MCR, a division of the 
MDPH Bureau of Health Information, Statistics, Research and Evaluation (BHISRE).  As 
mentioned, the MCR is a population-based surveillance system that began collecting 
information in 1982 on Massachusetts residents diagnosed with cancer in the state.  All 
                                                 
3 Because the MCR is a continual surveillance system, it is possible to review cancer incidence reports for 
more recent years (i.e., 2005 to the present) for defined geographic areas such as the one-mile radius 
around the landfill, even though complete statewide data are not available to allow for the calculation of 
actual cancer incidence rates. 
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newly diagnosed cancer cases among Massachusetts residents are required by law to be 
reported to the MCR within 6 months of the date of diagnosis (M.G.L. c.111 s.111B).   
Nine cancer types were evaluated in this investigation, including cancers of the bladder, 
brain and central nervous system, breast, kidney, liver, and lung and bronchus as well as 
leukemia, Hodgkin lymphoma and non-Hodgkin lymphoma.  [Coding for cancer types in 
this report follows the International Classification of Diseases for Oncology (ICD-O) 
system4.  See Appendix A for the coding definitions used in this report.]  All diagnoses 
reported to the MCR as primary cancers among residents of Northampton and 
Easthampton for the nine cancer types were included in the analysis.  Individuals 
diagnosed with cancer were selected for inclusion based on the residential address 
reported to the hospital or reporting medical facility at the time of diagnosis. 
The term "cancer" is used to describe a variety of diseases associated with abnormal cell 
and tissue growth.  Epidemiologic studies have revealed that different types of cancer are 
individual diseases with separate causes, risk factors, characteristics and patterns of 
survival (Berg 1996).  Cancers are classified by the location in the body where the 
disease originated (the primary site) and the tissue or cell type of the cancer (histology).  
Therefore, each of the cancer types reviewed in this report was evaluated separately.  
Cancers that occur as the result of the metastasis or the spread of a primary site cancer to 
another location in the body are not considered as separate cancers and therefore were not 
included in this analysis.  
                                                 
4 For purposes of this report, MDPH selected ICD-O coding definitions to address discrepancies that may 
arise in the interpretation of cancer incidence data due to the fact that City of Northampton hired a 
consulting firm to conduct similar analyses. 
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It should be noted that duplicate records have been eliminated from the MCR data used in 
this report.  Duplicate cases are additional reports of the same primary site cancer 
diagnosed in an individual by another health-care provider.  The decision that a case was 
a duplicate and should be excluded from the analyses was made by the MCR after 
consulting with the reporting hospital/diagnostic facility and obtaining additional 
information regarding the histology and/or pathology of the case.  However, reports of 
individuals with multiple primary site cancers were included as separate cases in this 
report.  In general, a diagnosis of a multiple primary cancer is defined by the MCR as a 
new cancer in a different location in the body or a new cancer of the same histology (cell 
type) as an earlier cancer, if diagnosed in the same primary site (original location in the 
body) more than 2 months after the initial diagnosis (MCR 2003).   
2. Calculation of Standardized Incidence Ratios (SIRs) 
To determine whether an elevation occurred among individuals diagnosed with cancer in 
Northampton or Easthampton, cancer incidence data were tabulated by gender according 
to eighteen age groups to compare the observed number of cancer diagnoses to the 
number that would be expected based on the statewide cancer rate.  Standardized 
incidence ratios (SIRs) were then calculated for four time periods, 1982-1986, 1987-
1991, 1992-1996, and 1997-2004, for each of the nine primary cancer types for each 
community and each CT, in order to evaluate patterns or trends in cancer incidence as 
compared to the statewide cancer experience. 
To calculate an SIR, it is necessary to obtain accurate population information.  The 
population figures used in this analysis were interpolated based on 1980, 1990, and 2000 
U.S. census data for Northampton and Easthampton (U.S. DOC 1980, 1990, and 2000).  
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Midpoint population estimates were calculated for each time period evaluated (i.e., 1984, 
1989, 1994 and 2000).  To estimate the population between census years, an assumption 
was made that the change in population occurred at a constant rate throughout the ten-
year interval between each census.5 
A CT is a geographic subdivision of a city or town designated by the United States 
Census Bureau.  Because age group and gender-specific population information is 
necessary to calculate incidence rates, the CT is the smallest geographic area for which 
cancer rates can be accurately calculated.  Specifically, a CT is a smaller statistical 
subdivision of a county as defined by the U.S. Census Bureau.  CTs usually contain 
between 1,500 and 8,000 persons and are designed to be homogenous with respect to 
population characteristics (U.S. DOC 2000).   
SIRs were not calculated for some cancer types in the smaller time periods and/or CTs 
due to the small number of observed cases (less than five).  It is standard BHISRE policy 
not to calculate rates with fewer than five observed diagnoses due to the instability of the 
rate.  However, the expected number of diagnoses was calculated during each time period 
and for each CT, and the observed and expected numbers of diagnoses were compared to 
determine whether excess numbers of cancer diagnoses were occurring. 
3. Interpretation of a Standardized Incidence Ratio (SIR) 
An SIR is an estimate of the occurrence of cancer in a population relative to what might 
be expected if the population had the same cancer experience as a larger comparison 
                                                 
5 Using slightly different population estimates or statistical methodologies, such as grouping ages 
differently or rounding off numbers at different points during calculations, may produce results slightly 
different from those published in this report. 
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population designated as "normal" or average.  Usually, the state as a whole is selected to 
be the comparison population.  Using the state of Massachusetts as a comparison 
population provides a stable population base for the calculation of incidence rates. 
Specifically, an SIR is the ratio of the observed number of cancer diagnoses in an area to 
the expected number of diagnoses multiplied by 100.  The population structure of each 
town is adjusted to the statewide incidence rate to calculate the number of expected 
cancer diagnoses.  The SIR is a comparison of the number of diagnoses in the specific 
area (i.e., city/town or census tract) to the statewide rate.  Comparison of SIRs between 
communities or census tracts is not possible because each of these areas has different 
population characteristics. 
An SIR of 100 indicates that the number of cancer diagnoses observed in the population 
being evaluated is equal to the number of cancer diagnoses expected in the comparison or 
"normal" population.  An SIR greater than 100 indicates that more cancer diagnoses 
occurred than were expected, and an SIR less than 100 indicates that fewer cancer 
diagnoses occurred than were expected.  Accordingly, an SIR of 150 is interpreted as 
50% more cancer diagnoses than the expected number; an SIR of 90 indicates 10% fewer 
cancer diagnoses than expected. 
Caution should be exercised, however, when interpreting an SIR.  The interpretation of 
an SIR depends on both the size and the stability of the SIR.  Two SIRs can have the 
same size but not the same stability.  For example, an SIR of 150 based on four expected 
diagnoses and six observed diagnoses indicates a 50% excess in cancer, but the excess is 
actually only two diagnoses.  Conversely, an SIR of 150 based on 400 expected 
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diagnoses and 600 observed diagnoses represents the same 50% excess in cancer, but 
because the SIR is based upon a greater number of diagnoses, the estimate is more stable.  
It is very unlikely that 200 excess diagnoses of cancer would occur by chance alone.  As 
a result of the instability of incidence rates based on small numbers of diagnoses, SIRs 
were not calculated when fewer than five diagnoses were observed for a particular cancer 
type. 
4. Calculation of the 95% Confidence Interval 
To help interpret or measure the stability of an SIR, the statistical significance of each 
SIR was assessed by calculating a 95% confidence interval (95% CI) to determine if the 
observed number of diagnoses is “significantly different” from the expected number or if 
the difference may be due solely to chance (Rothman and Boice 1982).  Specifically, a 
95% CI is the range of estimated SIR values that have a 95% probability of including the 
true SIR for the population.  If the 95% CI range does not include the value 100, then the 
disease rate in the study population is statistically significantly different from the 
comparison or "normal" population.  "Statistically significantly different" means there is 
less than a 5% chance that the observed difference (either increase or decrease) in the rate 
is the result of random fluctuation in the number of observed cancer diagnoses.   
For example, if a confidence interval does not include 100 and the interval is above 100 
(e.g., 105–130), there is a statistically significant excess in the number of cancer 
diagnoses.  Similarly, if the confidence interval does not include 100 and the interval is 
below 100 (e.g., 45–96), the number of cancer diagnoses is statistically significantly 
lower than expected.  If the confidence interval range includes 100, the true SIR may be 
100.  In this case, it cannot be determined with certainty that the difference between the 
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observed and expected number of diagnoses reflects a real cancer increase or decrease or 
is the result of chance.  It is important to note that statistical significance alone does not 
necessarily imply public health significance.  Determination of statistical significance is 
just one tool used to interpret cancer patterns in a community. 
In addition to the range of the estimates contained in the confidence interval, the width of 
the confidence interval also reflects the stability of the SIR estimate.  For example, a 
narrow confidence interval, such as 103–115, allows a fair level of certainty that the 
calculated SIR is close to the true SIR for the population.  A wide interval, for instance 
85–450, leaves considerable doubt about the true SIR, which could be much lower than 
or much higher than the calculated SIR.  This would indicate an unstable statistic.  Again, 
due to the instability of incidence rates based on small numbers of diagnoses, statistical 
significance was not assessed when fewer than five diagnoses were observed. 
5. Determination of Geographic Distribution of Cancer Cases 
In addition to calculating SIRs, the address at the time of diagnosis for each individual 
diagnosed with one of the nine cancer types in Northampton or Easthampton was 
geographically mapped using a computerized geographic information system (GIS) 
(ESRI 2005).  This allowed assignment of CT location for each individual diagnosed with 
cancer as well as an evaluation of the spatial distribution of the individuals at a smaller 
geographic level within CTs (i.e., neighborhoods).  The geographic pattern was 
determined using a qualitative evaluation of the point pattern of cancer diagnoses in each 
community as well as in CTs 8222.00 and 8224.01.  This evaluation included 
consideration of the population density variability of each CT through the use of GIS-
generated population density overlays.  In instances where the address information from 
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the MCR was incomplete, that is, did not include specific streets or street numbers, 
efforts were made to research those individuals diagnosed with cancer (e.g., by using 
telephone books issued within 2 years of an individual's diagnosis or searching files via 
the Registry of Motor Vehicles).  For confidentiality reasons, it is not possible to include 
maps showing the locations of individuals diagnosed with cancer in this report.  [Note: 
MDPH is bound by state and federal patient privacy and research laws not to reveal the 
name or any other identifying information of an individual diagnosed with cancer and 
reported to the MCR.] 
B. Results  
The following sections present cancer incidence rates for the communities of 
Northampton and Easthampton and for CT 8222.00 in Northampton and CT 8224.01 in 
Easthampton during the 23-year time period 1982-2004.  As shown in Figure 1, the 
Northampton Regional Landfill is located in CT 8222.00, near the border with CT 
8224.01 in Easthampton.  As mentioned, to evaluate possible trends over time as 
compared to the statewide cancer experience, these data were analyzed by four smaller 
time periods, 1982-1986, 1987-1991, 1992-1996 and 1997-2004.  Tables 1A through 1D 
summarize cancer incidence data for Northampton as a whole while Tables 2A through 
2D summarize data for Northampton’s CT 8222.00.  Cancer incidence data for the town 
of Easthampton as a whole and its CT 8224.01 are summarized in Tables 3A through 3D 
and 4A through 4D, respectively.  SIRs were not calculated for some cancer types, in 
these smaller time periods and/or CTs, due to the small number of observed cases (less 
than five).  As previously mentioned, the expected number of diagnoses was calculated 
during each time period and for each CT, and the observed and expected numbers of 
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diagnoses were compared to determine whether excess numbers of cancer diagnoses were 
occurring. 
In addition to calculating cancer incidence rates, the CAP also reviewed the types and 
distribution of all cancers diagnosed within a one-mile radius of the Northampton 
Regional Landfill since 1982.  This review covered 28 streets, in part or whole, in both 
Northampton and Easthampton neighborhoods within the one-mile radius (see Figure 2 
and Table 5).  This qualitative review allowed CAP to assess the types of cancers 
diagnosed as well as any spatial and/or temporal patterns. 
Risk factor summaries for each type of cancer evaluated are included in Appendix B. 
1. Northampton 
In general, cancer incidence rates in Northampton were approximately at or near the rates 
expected during each of the four time periods evaluated (see Tables 1A-1D).   In each of 
the four time periods evaluated, the incidence of the following five types of cancers in 
both genders was either less than expected or about as expected when compared to the 
statewide cancer experience: brain and CNS6, lung and bronchus, Hodgkin lymphoma, 
leukemia, and liver cancer.  For these five cancer types, if the number of observed 
diagnoses was greater than the number expected, the difference was based on one or two 
diagnoses. For incidence rates greater than expected, none of the differences between the 
numbers of observed and expected diagnoses were statistically significant, meaning that 
they most likely represent natural or random variation in the incidence of these five 
cancer types. 
                                                 
6 The incidence of brain and CNS cancer in Northampton was statistically significantly lower than expected 
in two of the four time periods:  1982-1986 and 1997-2004. 
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Breast Cancer 
The incidence rates of four types of cancer – breast, bladder, NHL, and kidney – showed 
somewhat greater variability. Breast cancer occurred slightly more often than expected 
during two of the four time periods evaluated: 1987-1991 and 1992-1996 (Tables 1B- 
1C). However, it is important to note that while there were differences between the 
numbers of observed and expected diagnoses during these two time periods, none were 
statistically significant.  During the earliest time period, however, more females in 
Northampton were diagnosed with breast cancer than expected, with 112 diagnoses 
observed compared to approximately 93 expected (Table 1A). This difference was of 
borderline statistical significance.  During the latest time period, a statistically significant 
elevation occurred in breast cancer in Northampton females with 285 diagnoses observed 
compared to approximately 249 expected (SIR = 115; 95% CI: 102-129).  An important 
distinction between the earliest and latest time periods, with respect to breast cancer 
diagnoses, is that in-situ (non-invasive) diagnoses are included in the latest time period 
but not the earliest time period.  The MCR began collecting in-situ breast cancer 
diagnoses in 1992.  It is important to note that the most recent time period evaluated 
constitutes an eight-year period while the other three time periods evaluated constitute 
five-year periods.   
Available risk factor information was reviewed for those Northampton women diagnosed 
with breast cancer between 1982 and 1986 and between 1997 and 2004.  According to the 
American Cancer Society (ACS), the chance of an American woman developing invasive 
breast cancer at some time in her life is about 1 in 8 (12%).  The ACS also reports that 
about 2 out of 3 (67%) women with invasive breast cancer are age 55 or older when they 
16 
are diagnosed while about 1 in 8 invasive breast cancer diagnoses are among women 
younger than age 45 (ACS 2007a).  The average age of females diagnosed with breast 
cancer in Northampton from 1997-2004 was 61 years of age, which is the same as the 
average age for females diagnosed with breast cancer statewide during that time period.  
The average age of females diagnosed with breast cancer in Northampton from 1982-
1986 was approximately 67 years of age, compared to 64 years of age for women 
statewide.  
MDPH reviewed cancer staging information for women diagnosed with breast cancer in 
Northampton for the period 1997-2004.  Staging describes the extent of spread of an 
individual’s cancer; from a public health perspective, earlier breast cancer staging reflects 
to some extent whether women are being screened early and regularly for breast cancer. 
In Northampton, approximately 33% of the women diagnosed with breast cancer between 
1997 and 2004 were diagnosed with in-situ (non-invasive) breast cancer compared to 
24% statewide. 
The ACS also reports that women, who as children or young adults, had radiation therapy 
to the chest as treatment for another cancer (such as Hodgkin lymphoma or NHL) are at 
significantly higher risk for breast cancer.  Review of MCR data showed that 14 of the 
112 women diagnosed with breast cancer during 1982-1986 had been previously 
diagnosed with cancer.  For the period 1997-2004, 84 of the 285 women diagnosed with 
breast cancer had been previously diagnosed with cancer.  While it is unknown whether 
radiation was used for treatment of their previous cancers, it is possible that such 
treatment may have contributed to some breast cancer diagnoses.    
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Review of address information at the time of diagnosis for individuals diagnosed with 
breast cancer between 1982-1986 and 1997-2004 in Northampton showed no unusual 
patterns or geographic clustering in the city of Northampton or in the vicinity of the 
Northampton Regional Landfill.  In addition, a review of the geographic distribution of 
women diagnosed with breast cancer in the other two time periods similarly did not show 
any unusual spatial patterns. 
Bladder Cancer 
The incidence of bladder cancer in Northampton males was lower than expected in each 
of the four time periods evaluated.  For Northampton females, the incidence of bladder 
cancer was approximately as expected during the first three time periods but greater than 
expected during the last time period.  For 1982-1986, fewer Northampton females were 
diagnosed with bladder cancer than expected: 5 observed compared to 9 expected.  For 
1987-1991, 11 females were diagnosed with bladder cancer while approximately 8 were 
expected.  For 1992-1996, 14 females were diagnosed with bladder cancer while 
approximately 11 were expected.  For 1997-2004, 28 females were diagnosed with 
bladder cancer while approximately 19 were expected.  It is important to note that the 
MCR first began collecting in-situ bladder cancer diagnoses in 1992.  Therefore, the 
number of individuals reported in the MCR with bladder cancer increased statewide. 
Also, as discussed previously, the latest time period constitutes an eight-year period while 
the other three time periods evaluated constitute five-year periods.   
Available risk factor information was reviewed for those Northampton females diagnosed 
with bladder cancer between 1987 and 2004.  According to the American Cancer Society 
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(ACS), over 70% of people diagnosed with bladder cancer are over 65 years of age and 
nearly 90% are over age 55 at diagnosis.  For Northampton females diagnosed between 
1987 and 2004, 79% were over 65 years of age at diagnosis and 91% were over age 55 at 
diagnosis. The average age at diagnosis for the Northampton females was 73 compared to 
71 for all Massachusetts females diagnosed with bladder cancer during this same time 
period.  The greatest risk factor for bladder cancer is smoking.  According to the ACS, 
smokers are more than twice as likely as non-smokers to develop bladder cancer.  Other 
risk factors associated with an increased risk of bladder cancer include exposure to 
certain industrial chemicals, particularly in occupational settings such as the dye, rubber, 
leather, textiles, painting and printing industries; a history of chronic bladder 
inflammation; bladder birth defects; genetics; certain chemotherapeutic agents and 
radiation therapies for previous cancers; high levels of arsenic in drinking water; and, an 
individual’s fluid consumption (ACS 2007d). 
Of the 53 females, seven reported an occupation associated with an increased risk of 
developing bladder cancer; however, information regarding specific job duties that could 
help to further define exposure potential for these individuals was not available. Tobacco 
use history was reviewed for those Northampton females diagnosed with bladder cancer 
between 1987 and 2004.  Smoking history was unknown for 18 of the 53 females 
diagnosed during this time period.  Eighteen of the 35 females (51%) for whom smoking 
history was reported to the MCR were current or former smokers at the time of their 
bladder cancer diagnosis, compared to 60% statewide.        
The spatial distribution of place of residence for Northampton females diagnosed with 
bladder cancer between 1987 and 2004 was also reviewed.  The geographic distribution 
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of the reported residences of Northampton females diagnosed with bladder cancer during 
this time period did not appear unusual and closely followed the population distribution 
of the city of Northampton.  No unusual clustering around the landfill was observed.  
MDPH also evaluated the geographic distribution of residence at diagnosis for those 
females with bladder cancer who did not have a history of smoking as well as for those 
females with no potential for an occupational exposure, and again found no unusual 
spatial patterns. The spatial patterns for both groups closely followed the population 
density of the city. 
Non-Hodgkin Lymphoma 
For three of the four time periods evaluated (1987-1991, 1992-1996, and 1997-2004), the 
incidence of NHL in Northampton, as a whole, was either less than expected or as 
expected for both genders (Tables 1B -1D).  From 1982-1986, however, more individuals 
were diagnosed with NHL than expected when compared to the statewide incidence rate 
(25 observed versus approximately 20 expected) (Table 1A).  This elevation occurred 
among both males and females, with approximately two more males and three more 
females being diagnosed with NHL during this time period than expected.  Neither of 
these elevations was statistically significant.   
Available risk factor information was reviewed for those Northampton residents 
diagnosed with NHL between 1982 and 1986.  According to the American Cancer 
Society (ACS), over 95% of individuals diagnosed with NHL are adults. The type of non-
Hodgkin lymphoma seen in children is often very different from that seen in adults. The 
average age of individuals at diagnosis is in the 60s and about half of the individuals 
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diagnosed with NHL are over 65 years of age (ACS 2007b).  The average age of 
individuals diagnosed with NHL in Northampton during this time period was 64 years 
and 48% of the individuals were over age 65 at the time of their diagnosis.   
There are many different types of NHL.  The most common types of NHL can be 
grouped into two broad classifications, B-cell or T-cell lymphoma.  Nationally, B-cell 
lymphoma accounts for approximately 85% of all NHL diagnoses (ACS 2007b).  In 
Northampton, 84% of individuals diagnosed with NHL between 1982 and 1986 were 
diagnosed with the B-cell subtype.   
Overall, review of address information at the time of diagnosis for individuals diagnosed 
with NHL between 1982 and 1986 showed no unusual pattern.  Two individuals, who 
were diagnosed with NHL within three months of one another, did reside in close 
proximity to one another at the time of their diagnosis.   However, these individuals lived 
in a fairly densely populated area of Northampton.  It is also worthy of note that this area 
is approximately four miles away from the landfill.  
Kidney Cancer 
For Northampton as a whole, kidney cancer in females was statistically significantly 
elevated during the last time period of 1997–2004 (Table 1D).  Twenty-three diagnoses 
were observed while 13.0 would be expected, based on the statewide incidence of kidney 
cancer in females; the SIR was 176 (95% CI: 112-265).  In the previous three time 
periods, kidney cancer in females was either as expected or below the expected rate.  In 
males, kidney cancer incidence was about as expected during the four time periods.  
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According to the ACS, the average age at the time of diagnosis of kidney cancer is 65. 
With one exception, kidney cancer is very uncommon under age 45, and its incidence is 
highest between the ages of 55 and 84.  Wilm’s tumor, which represents about 5% of all 
kidney cancers, is most common in children.  In Northampton, the average age of females 
diagnosed with kidney cancer between 1997 and 2004 was 64 years.  Two of the 23 
females were under age 19 at the time of their diagnosis and both were diagnosed with 
Wilm’s tumor. 
The histologies or subtypes of kidney cancer in the 21 adult females were also reviewed 
and compared to what would be expected, based on the medical literature and national 
cancer statistics.  Between 80 and 90% of all kidney cancers are renal cell carcinomas 
(ACS 2007c).  In Northampton, 16 of the 19 (84%) adult females for whom subtype 
information was available were diagnosed with renal cell carcinomas. Subtype 
information was not known for two of the 21 adult females. 
Some lifestyle-related risk factors are associated with the development of kidney cancer.  
They include smoking and obesity. Occupational exposure to some chemicals has also 
played a role in the development of kidney cancer (ACS 2007c). Of the 16 adult females 
diagnosed with kidney cancer in Northampton between 1997 and 2004 for whom their 
smoking history was reported to the MCR, 10 reported being current or former smokers 
at the time of their diagnosis.  History of tobacco use was unknown for 5 of the 21 adult 
females. Review of occupational information reported to the MCR for the 21 adult 
females diagnosed with kidney cancer showed that five of the 21 reported occupations 
where exposure to chemicals associated with kidney cancer could have occurred.  
However, specific job duty information that could further define exposure potential was 
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not available through the MCR. Occupation was reported as “unknown” or “at home” for 
12 of the 21 adult females.  Information on factors such as obesity is not reported to the 
MCR.  (A more detailed discussion of all of the risk factors associated with the 
development of kidney cancer is provided in Appendix B.) 
The geographic distribution of the reported residences of Northampton females diagnosed 
with kidney cancer during this time period did not appear unusual and closely followed 
the population distribution of the city of Northampton.  MDPH also evaluated the 
geographic distribution of residence at diagnosis for those females with kidney cancer 
who did not have a history of smoking as well as for those females with no potential for 
an occupational exposure, and found no unusual spatial patterns. The spatial patterns for 
both groups closely followed the population density of the city. In addition, the 
distribution of year at diagnosis among the 23 females was spread fairly evenly across the 
8-year period.  There was no temporal clustering by year of diagnosis.  
2. Northampton CT 8222.00 
Review of cancer incidence rates for males and females combined in CT 8222.00 in 
Northampton showed that cancer incidence occurred as or below expected for most of the 
nine cancer types evaluated (Tables 2A – 2D).  In all four time periods, individuals living 
in CT 8222.00 were diagnosed with liver cancer less often than expected based on the 
statewide liver cancer experience, with one individual diagnosed with liver cancer over 
the 23-year period.  The incidence of Hodgkin lymphoma, non-Hodgkin lymphoma, 
bladder cancer and brain and CNS cancer occurred approximately as or below expected 
in each of the time periods evaluated.  Any observed elevations were based on one or two 
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individuals above the expected number and were not statistically significant.  Elevations 
did exist for a few of the cancer types in some time periods, most were not statistically 
significant and likely represent natural variability in rates. These elevations are discussed 
below. There were two statistically significant elevations in this CT during different time 
periods. These included leukemia incidence in 1992-1996 and breast cancer incidence in 
1997-2004, both of which are also discussed below.  
Breast Cancer 
For three of the four time periods evaluated (1982-1986, 1992-1996, and 1987-1991), the 
incidence of breast cancer in Northampton women from CT 8222.00 was not statistically 
significantly different from the statewide breast cancer experience (Tables 2A, 2B, and 
2C).  In 1982-1986, fewer females in this CT were diagnosed with breast cancer than 
would be expected: 13 observed versus 14.2 expected.  In 1987-1991, 22 females were 
diagnosed with breast cancer when approximately 18 were expected. In 1992-1996, the 
incidence was again below the expected rate:  18 observed versus 25.1 expected. 
Between 1997 and 2004, 68 women were diagnosed with breast cancer in this CT 
compared to approximately 53 expected (Table 2D).  This elevation was statistically 
significant (SIR=129; 95% CI: 101-164).  As discussed in the previous section on breast 
cancer incidence citywide in Northampton, it is important to note that the latest time 
period covers eight years (compared to five years for the previous three time periods) and 
includes in-situ (non-invasive) breast cancer diagnoses. 
Available risk factor information was reviewed for those Northampton females diagnosed 
with breast cancer during the most recent time period.  The average age at diagnosis for 
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females diagnosed with breast cancer during this time period was younger than the 
statewide average (56 years of age in Northampton CT 8222.00 compared to 61 years of 
age statewide).  A review of the spatial distribution of residence at diagnosis for 
Northampton females diagnosed with breast cancer while living in CT 8222.00 showed 
that the pattern closely followed the population density patterns within the census tract. 
MDPH reviewed cancer staging information for women diagnosed with breast cancer in 
Northampton CT 8222.00 for the period 1997-2004.  Staging describes the extent of 
spread of an individual’s cancer; from a public health perspective, earlier breast cancer 
staging reflects to some extent whether women are being screened early and regularly for 
breast cancer. In Northampton CT 8222.00, approximately 43% of the women diagnosed 
with breast cancer between 1997 and 2004 were diagnosed with in-situ (non-invasive) 
breast cancer compared to 24% statewide.   
Leukemia 
The incidence of leukemia occurred about as expected or less than expected in 
Northampton CT 8222.00 for three of the four time periods evaluated.  From 1992-1996, 
however, leukemia was statistically significantly elevated; seven individuals were 
diagnosed while approximately three would have been expected (SIR 277, 95% CI: 111-
571).  This elevation was due to the number of reported diagnoses in females, with 6 
diagnoses observed versus approximately 1 expected.   
 Leukemia is grouped into four subtypes based on the type of white blood cell affected 
and how quickly the disease develops.  These subtypes are acute myeloid leukemia 
(AML), acute lymphocytic leukemia (ALL), chronic myeloid leukemia (CML), and 
25 
chronic lymphocytic leukemia (CLL).  The etiologies and risk factors for each subtype of 
leukemia are different.  AML is the most commonly diagnosed subtype of leukemia.  
According to the National Cancer Institute, there are about 10,600 new diagnoses of 
AML annually, representing about 34% of leukemia diagnoses each year (NCI 2003).  
AML occurs in both adults and children.  In CT 8222.00, four of the six females 
diagnosed with leukemia were diagnosed with AML.   
Risk factors for AML include smoking and long-term occupational exposure to high 
levels of benzene or formaldehyde.  Additionally, individuals previously diagnosed with 
cancer who were treated with certain cancer-fighting drugs (chemotherapy) or with high-
dose radiation may later develop leukemia. For example, drugs known as alkylating 
agents are associated with the development of leukemia many years later (NCI 2003).  
(For a fuller discussion of risk factors for leukemia, see Appendix B.) Review of risk 
factor data available from the MCR identified one of the four individuals diagnosed with 
AML as having had a previous cancer diagnosis.  This patient may have received 
treatment for their initial cancer that could have contributed to their subsequent leukemia 
diagnosis.  However, it is not possible using readily-available information from the MCR 
to determine whether this individual actually received chemotherapy or radiation therapy 
for his/her previous cancer.   Additionally, two of the four females diagnosed with AML 
reported to the MCR that they were current or former tobacco users.  One individual was 
reported as a nonsmoker and the smoking status was reported as unknown for the 
remaining individual.   
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The geographic distribution of all of the individuals diagnosed with leukemia in CT 
8222.00 closely followed the patterns of population density in this CT. No unusual spatial 
patterns were noted when the residences at diagnosis were mapped.  
Kidney Cancer 
In the three earliest time periods, with one exception, kidney cancer occurred about as or 
less often than expected in CT 8222.00 (Tables 2A-2C).  During 1982-1986, more males 
in CT 8222.00 were diagnosed with kidney cancer than expected (4 diagnoses observed 
versus one expected). The incidence of kidney cancer was also elevated in Northampton 
CT 8222.00 during the most recent time period among both males and females.  From 
1997-2004, eight males were diagnosed with kidney cancer while approximately four 
would have been expected and four females were diagnosed while approximately two 
would have been expected. This elevation was not statistically significant.  
Available risk factor information was reviewed for those Northampton residents of CT 
8222.00 diagnosed with kidney cancer during the latter time period.  According to the 
American Cancer Society, the incidence of kidney cancer is the highest in individuals 
between 55 and 84 years of age (ACS 2007c).  In Northampton CT 8222.00, the average 
age of the 12 individuals diagnosed with kidney cancer was 68 years.  In addition, the 
ACS reports smoking as a risk factor for kidney cancer (ACS 2007c).  Of the 12 
individuals diagnosed with kidney cancer, tobacco history was reported for 10 
individuals.  Of these 10, five reported being current or former tobacco users at the time 
of their diagnosis.   
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Most of the individuals diagnosed with kidney cancer did not live in close proximity to 
one another or the Northampton Regional Landfill at the time of their diagnosis.  There 
was one exception. Three males and one female lived in close proximity to one another; 
however, their residences were in a densely populated area of Northampton and were 
more than 3 miles from the landfill. 
Lung and Bronchus Cancer 
In Northampton CT 8222.00, fewer individuals were diagnosed with cancer of the lung or 
bronchus than expected, based on the statewide experience, during each of the first three 
time periods.  From 1997-2004, however, more individuals were diagnosed with cancer 
of the lung or bronchus than expected.  This elevation, although not statistically 
significant, was due to an elevated incidence among females.  Twenty-one females were 
diagnosed with cancer of the lung or bronchus while approximately 15 would be 
expected.  Of the 21 females diagnosed, 19 were reported to the MCR as current or 
former smokers.  Smoking status was unknown for one individual and the remaining 
individual reported being a nonsmoker.  The geographic distribution of individuals 
diagnosed with cancer of the lung or bronchus closely matched the population density of 
Northampton.  Additionally, there was no spatial clustering in the area surrounding the 
Northampton Regional Landfill. 
3. Easthampton 
In general, cancer incidence rates in Easthampton were approximately at or near the rates 
expected during each of the four time periods evaluated (see Tables 3A-3D).   In each of 
the four time periods evaluated, the incidence of the following six types of cancers in 
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both genders was either less than expected or about as expected when compared to the 
statewide cancer experience: bladder, breast, Hodgkin lymphoma, leukemia, NHL, and 
liver cancer.  Except for NHL during one time period, any differences between the 
number of observed diagnoses and the number expected for these six types of cancers 
were based on one or two diagnoses.  (During the 1997-2004 time period, 17 diagnoses 
of NHL were reported among males in Easthampton compared to approximately 14 
expected.)  With one exception, none of the differences between the numbers of observed 
and expected diagnoses were statistically significant, meaning that they most likely 
represent natural or random variation in the incidence of these six cancer types.  The one 
exception was that the incidence of NHL was statistically significantly lower than 
expected during 1992-1996. 
Brain and CNS Cancer 
The incidence rates of three types of cancer – brain and CNS, kidney, and lung and 
bronchus – showed somewhat greater variability.  In three of the four time periods 
evaluated, more individuals were diagnosed with cancer of the brain or CNS cancer in 
Easthampton than would be expected (see Tables 3A, 3B, and 3D).  None of these 
elevations were statistically significant.   
Between 1982 and 1986, a total of 11 males and females were diagnosed with cancer of 
the brain or CNS while seven diagnoses would have been expected based on the 
statewide experience, however this difference was not statistically significant.  Of the 11 
individuals diagnosed, two were diagnosed with a cancer of the CNS; the remaining nine 
were diagnosed with brain cancer.   
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There are few known risk factors for brain or CNS cancer.  According to the ACS, the 
only known environmental risk factor for brain or CNS cancer is exposure to radiation 
(ACS 2006a).  Today, because the health risks associated with most types of radiation are 
known, it has been established that radiation-induced tumors in non-occupationally 
exposed populations are generally the result of treatment for a previous cancer diagnosis. 
Other suspected risk factors for brain or CNS cancer are exposure to chemicals such as 
vinyl chloride and petroleum products (ACS 2006a).  Occupation was reported as 
unknown or retired to the MCR, with no further information, for six of the 11 individuals.  
None of the remaining five individuals reported their usual occupation as one that might 
be associated with exposure to these chemicals; however, a complete occupational history 
is not provided to the MCR.  Review of MCR data for the 11 individuals diagnosed with 
brain or CNS cancer showed that none had been previously diagnosed with cancer. No 
geographical concentrations of diagnoses were observed among the 11 individuals that 
could not be attributed to population density.   
From 1987-1991, eleven individuals were diagnosed with cancer of the brain or CNS in 
Easthampton.  Approximately eight diagnoses would have been expected based on the 
statewide brain and CNS cancer experience.  The number of females diagnosed with 
brain or CNS cancer during this time period was approximately equal to the number 
expected, while slightly more males were diagnosed than expected (7 observed versus 4 
expected).  This difference was not statistically significant.  
As with the previous time period, a review of MCR data did not indicate that any of the 
11 individuals had been previously diagnosed with cancer.   Occupation was reported to 
the MCR as retired or unknown for four of the 11 individuals.  Four other individuals 
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reported their usual occupation as one where an exposure thought to increase the risk of 
brain or CNS cancer might have been possible.  The usual occupations reported for the 
remaining three individuals were ones not associated with possible occupational 
exposures related to brain or CNS cancers.  Review of the geographical distribution of 
the 11 individuals diagnosed with a brain or CNS cancer between 1987 and 1991 in 
Easthampton did not show any unusual geographic clustering in any one part of 
Easthampton or in the vicinity of the Northampton Regional Landfill. 
From 1992-1996, the incidence of brain and CNS cancer in females occurred about as 
expected in Easthampton while fewer males were diagnosed with this type of cancer than 
expected.   
In the most recent time period (1997-2004), more individuals were diagnosed with cancer 
of the brain or CNS than expected in the city of Easthampton.  This was due to an 
elevation among females (15 observed versus approximately 10 expected) that was not 
statistically significant.  The incidence of brain or CNS cancer in males was as expected 
during this time period. One of the 15 females diagnosed with brain or CNS cancer had 
been previously diagnosed with cancer; however, it is unknown whether radiation was 
used for treatment of that cancer.  Occupational history was not reported to the MCR for 
three females.   For the remaining 12 females, none reported an occupation where an 
exposure to vinyl chloride or petroleum products seemed likely.   Finally, review of 
address at diagnosis for these females did not show an unusual concentration in any area 
of Easthampton or surrounding the Northampton Regional Landfill.   
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The incidence of brain and CNS cancer in Easthampton fluctuated over the course of the 
23-year period evaluated, with no consistent pattern emerging.  For males, the incidence 
of brain and CNS cancer was about as expected in the first time period, with six 
diagnoses observed compared to approximately four expected; the difference was not 
statistically significant.  Similarly, in the second time period, seven males were diagnosed 
with brain and CNS cancer when approximately four were expected; the difference was 
not statistically significant.  In the third time period, the incidence of brain and CNS 
cancer in males was lower than expected with one diagnoses reported compared to four 
expected.  In the last time period, the incidence of brain and CNS cancer in males was as 
expected, with eight diagnoses observed and eight expected.  For females, in the first 
three time periods, the incidence of brain and CNS cancer was either about as expected or 
lower than expected. For 1982-1986, five diagnoses were reported compared to 
approximately four expected.  For 1987-1991, the incidence of brain and CNS cancer in 
females was as expected: four diagnoses reported compared to four diagnoses expected.  
For 1992-1996, fewer diagnoses occurred in females than expected: three observed 
compared to approximately four expected.  In the last time period, more females were 
diagnosed with brain and CNS cancer than expected: 15 diagnoses observed compared to 
10 diagnoses expected; this difference was not statistically significant. 
When the spatial distribution of residence at diagnosis was examined, no unusual 
geographic patterns emerged.  The diagnoses were evenly spread across the town, with 
no particular geographic clustering.  CAP also examined the age at diagnosis for the 
various subtypes of brain and CNS cancer diagnosed in Easthampton residents in relation 
to what is reported in the medical literature.  The subtypes of brain and CNS cancers in 
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Easthampton, and the ages at diagnosis for the various subtypes, were consistent with 
what would be expected.  The relative percentages of brain and CNS cancer subtypes in 
Easthampton followed those reported by the American Cancer Society, with the majority 
of diagnoses being gliomas (a general category that includes astrocytomas, 
oligodendrogliomas, and ependymomas) followed by meningiomas (ACS 2006a).  In 
addition, no unusual pattern with respect to age at diagnosis was noted.  Among the six 
children/adolescents (ages 19 and younger) diagnosed with brain cancer during the 23-
year period, all were diagnosed with the most common subtype among children, 
astrocytoma. 
Kidney Cancer  
The number of individuals diagnosed with kidney cancer in Easthampton during three of 
the four time periods evaluated was below or approximately equal to the expected 
number (see Table 3B, 3C, and 3D).  In the earliest time period evaluated, from 1982-
1986, the incidence of kidney cancer in males was about as expected while for females, 
six diagnoses were reported to the MCR when approximately two would have been 
expected.  This elevation was not statistically significant.   
Lung and Bronchus Cancer 
The incidence of lung and bronchus cancer in Easthampton was below expected for 
males and females combined in three of the four time periods and for each gender when 
evaluated separately.  For the 1992-1996 time period, there was an elevation in the 
incidence of lung and bronchus cancer in females with 29 diagnoses reported while 
approximately 23 would be expected.  This difference was not statistically significant. In 
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the subsequent time period, 1997-2004, the incidence of lung and bronchus cancer in 
Easthampton females was statistically significantly lower than expected. During this 
same time period of 1997-2004, there was an elevation in males, with 59 diagnoses 
reported while approximately 52 would be expected; again, however, this difference was 
not statistically significant.  Although an elevation in the incidence of lung and bronchus 
cancer occurred in each gender for one time period, the elevations do not represent a 
consistent trend and most likely represent natural random variation in the incidence of 
this type of cancer. 
4. Easthampton CT 8224.01 
Review of cancer incidence data for individuals who reported an address within CT 
8224.017 at the time of their diagnosis showed that, for six of the nine cancer types, the 
incidence was either below expected or about as expected in each of the four time periods 
evaluated.  Any observed elevations were based on one or two diagnoses above the 
expected number of individuals. These elevations were not statistically significant. For 
three cancer types – lung and bronchus, brain and CNS, and kidney – there was more 
variability in their incidence rates.  Although more fluctuation in these rates was noted, 
no statistically significant elevations were seen. 
Lung and bronchus cancer in males during the 1992-1996 time period was elevated with 
12 diagnoses reported to the MCR when approximately eight would have been expected.  
                                                 
7 In 1990, the U.S. Census Bureau split what was then Easthampton CT 8224 into two census tracts referred 
to as 8224.01and 8224.02.  CT 8224 in 1980 was the Easthampton CT closest to the Northampton Regional 
Landfill, and then in 1990, this area of Easthampton became CT 8224.01.  For this report, MDPH refers to 
CT 8224.01 as the one in closest proximity to the landfill.  For accuracy, it is important to note that the 
population data for the years between 1982 and 1991 reflect the CT 8224 boundaries. 
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This difference was not statistically significant.  In the other three time periods evaluated, 
the incidence of lung and bronchus cancer in males in this CT was either less than or as 
expected.  In the first two time periods, brain and CNS cancer incidence was slightly 
elevated. In 1982-1986, eight diagnoses in males and females combined were observed 
compared to approximately four diagnoses expected; this difference was not statistically 
significant.  In 1987-1991, although the number of observed diagnoses in females was as 
expected, there were six diagnoses of brain and CNS cancer in Easthampton males in this 
CT when approximately two would be expected; this difference was not statistically 
significant.  In the subsequent two time periods, the incidence of brain and CNS cancer in 
this CT was either less than expected or near expected. For kidney cancer in Easthampton 
CT 8224.01, the incidence was about as expected during the last three time periods 
evaluated.  In the first time period, however, it was slightly elevated in females with four 
diagnoses reported when approximately one was expected. In males during this time 
period, three diagnoses were reported when approximately two were expected.  
5. One Mile Radius Surrounding the Northampton Regional 
Landfill 
To further address the concerns of residents living in close proximity to the Northampton 
Regional Landfill, an analysis of all types of cancer diagnosed in this area was conducted.  
For this analysis, the pattern of all cancer diagnoses was reviewed for an area that 
constituted a one-mile radius around the landfill. This is an area that is bordered to the 
east by Sovereign Way, to the south by Lexington Drive, to the west by Loudville Road, 
and to the north by Ryan Road (see Figure 2).  Twenty-eight different streets, in part or 
whole, were included in this area (see Table 5 for a list of the streets).  In general, our 
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review found no atypical pattern of cancer in the neighborhood surrounding the 
Northampton Regional Landfill.  From 1982 to the present, a total of 24 different types of 
cancer were diagnosed among residents of this area, representing the occurrence of many 
different diseases.   
The most commonly reported diagnoses included cancers of the lung and bronchus, 
breast, prostate, and colon/rectum.  These are the four most common types of cancer 
diagnosed among men and women in Massachusetts and this pattern is also consistent 
with national trends in cancer incidence (ACS 2006b).  Together, these cancer types 
represented more than half (58%) of the cancer diagnoses in this one-mile area.  There 
were also a number of other cancer types diagnosed among residents of these areas of 
Northampton and Easthampton over the 26-year period reviewed.  These types included 
cancers of the bladder, cervix, kidney, brain and CNS, testes, stomach, oral cavity and 
pharynx, ovary, thyroid, and uterus as well as Hodgkin lymphoma, mesothelioma, 
leukemia, melanoma of the skin, and non-Hodgkin’s lymphoma.  The types of cancer that 
occurred varied and there was no specific pattern or geographic concentration of any one 
cancer type within this one-mile area.  Also, for any given type of cancer, the years of 
diagnosis varied throughout the 26 years reviewed, indicating no apparent trend or 
pattern in the time of diagnosis. 
Because the MCR collects some information related to risk factors for individuals 
diagnosed with cancer, these data were reviewed to better characterize the cancer 
incidence patterns within the one-mile radius of the landfill.  Age at diagnosis, gender, 
smoking history, and occupation were reviewed for those individuals diagnosed with 
cancer and whose residence was within the one-mile radius of the landfill. 
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Age is an important risk factor in many cancers.  Different cancers occur with different 
frequencies among the various age groups, and most cancer types occur more frequently 
in older populations (i.e., age 50 and over).  The average age at diagnosis among 
individuals in the one-mile radius with any type of cancer was 63 years and the majority 
of individuals (82%) were age 50 or older when they were diagnosed.  For each particular 
type of cancer, the age at diagnosis was reviewed and determined to be consistent with 
what is reported in the epidemiological literature for that cancer type.    
Because cigarette smoking is also an important risk factor in the development of several 
cancer types, including cancers of the lung and bronchus, oral cavity and pharynx, 
colon/rectum, bladder, kidney, and stomach, smoking history was reviewed for each 
individual within the one-mile radius who had been diagnosed with a potentially 
smoking-related cancer.  Of the 43 individuals with one of these cancer types, 27 (63%) 
reported being current or former smokers at the time of diagnosis, eight reported being 
non-smokers, and smoking history was unknown for the remaining eight individuals.  
Therefore, smoking more than likely played some role in the development of cancer 
among some residents of the one-mile area surrounding the landfill.   
In addition, some occupational exposures have been associated with an increased risk for 
developing certain types of cancer.  A review of occupation as reported to the MCR 
showed that seven individuals diagnosed with cancer in the one-mile radius worked in 
jobs that may be associated with an increased risk for developing the particular type of 
cancer.  However, specific job duty information that could further define exposure 
potential was not available through the MCR 
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Finally, analysis of the geographic distribution of place of residence for individuals 
diagnosed with cancer within the one-mile radius did not reveal any atypical spatial 
patterns that would suggest an association with a common environmental factor.   
III. REPRODUCTIVE OUTCOME DATA  
Birth Defects 
In response to concerns about birth defects in areas surrounding the Northampton 
Regional Landfill, the CAP obtained birth defects data for Northampton and Easthampton 
from the Massachusetts Center for Birth Defects Research and Prevention within 
MDPH’s Bureau of Family Health and Nutrition.  Massachusetts implemented a 
statewide birth defects surveillance system in 1997, with 2000 being the first year for 
which data on birth defects are available.  The aim of the surveillance system is to 
identify major structural birth defects in fetuses of at least 20 weeks gestational age and 
infants up to one year of age.  Most structural defects fall into the following categories: 
central nervous system, eyes, ears, cardiovascular/respiratory, orofacial, gastrointestinal, 
genitourinary, and musculoskeletal.  Other conditions monitored in this system include 
genetic and chromosomal abnormalities.  The surveillance system involves trained 
physicians and medical/public health personnel who validate birth defects cases reported 
to the MDPH.  The birth defect cases can be evaluated by city or town, with a child 
assigned to the city/town of the mother’s residence at the time of birth. 
Population-based birth defect rates are available for the years 2000 through 2003.  Birth 
defect rates are calculated as the number of birth defect diagnoses at a point in time 
(prevalence) and are presented per 10,000 births. Ninety-five percent confidence intervals 
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are also provided to assess the magnitude and stability of the prevalence estimate.   If the 
confidence intervals for the community do not overlap with (i.e. fall within the range of) 
the state’s confidence intervals, then the rates are considered to be statistically 
significantly different.  If the confidence intervals around the two rates being compared 
do overlap, then it is likely that the differences in the two rates may be due to chance or 
natural random variation. 
The causes of birth defects are poorly understood.  Genetic and environmental factors 
have been identified in certain defects.  These include: prenatal environmental factors, 
such as infections (e.g. rubella), exposures to medications, chemical contamination of 
environmental media (such as drinking water), drug or alcohol abuse, and nutritional 
deficiencies.  It is also known that a single abnormal gene can cause certain birth defects.  
The gene may have an error in its code, a missing piece or extra genetic material, all of 
which can result in birth defects/congenital malformations.  Other birth defects may be 
caused by a combination of factors, such as genes interacting with environmental factors.  
For 60-70% of major birth defects, no known cause has been identified. 
Table 6 shows the number of birth defects diagnoses reported to the MDPH Center for 
Birth Defects Research and Prevention for Northampton and Easthampton for the four-
year period of 2000 through 2003, as well as for the state of Massachusetts as a whole for 
comparison purposes.  There were a total of 16 and 12 birth defect diagnoses in 
Northampton and Easthampton, respectively, over the four-year period.  Although both 
communities experienced a birth defect rate somewhat higher than the state’s, neither was 
statistically significantly elevated. Both rates had large confidence intervals, indicating 
their relative statistical instability. Also, while birth defects are grouped together due to 
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the small number of events, like cancer, different outcomes are thought to be etiologically 
different.  For example, cleft palate and cleft lip are considered distinct outcomes.   
A clinical geneticist within the MDPH Center for Birth Defects Research and Prevention 
reviewed the individual birth defects and examined them from the perspective of 
potential teratogenic exposures, looking for patterns of multiple defects or early 
exposures within the Northampton and Easthampton children diagnosed with a birth 
defect.  (A teratogen is an agent that can cause developmental abnormalities in a fetus.)  
The clinical geneticist did not identify any unusual patterns of defects within either 
community.   
In addition, the CAP evaluated birth defects in Northampton and Easthampton during the 
2000-2003 time period with respect to geographic distribution of the mother’s residence, 
as reported at the time of the child’s birth.  Birth defect cases which occurred within this 
time period in Northampton and Easthampton were geocoded and mapped.  The spatial 
distribution of birth defects in both communities was reviewed to assess if there were any 
atypical groupings or concentrations of particular birth defects within any particular areas 
in the communities.  No spatial patterns were observed in either community, and the 
distribution was consistent with population density within each community.   
Low Birthweight  
The prevalence of low birthweight births was another concern expressed by community 
members living near the Northampton Regional Landfill.  To address this concern, the 
CAP reviewed rates of low birthweight births in Northampton, Easthampton, and the 
state as a whole for the years 2000-2005.   
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Low birthweight is considered to be anything below 2500 grams (approximately 5 
pounds, 8 ounces) when a newborn is carried to full term.  Babies born with a low 
birthweight are alternatively referred to as “small for gestational age,” and the terms are 
used interchangeably.  There are many risk factors for low birthweight, including 
insufficient placental growth, growth restriction, maternal smoking, and other factors.  
Growth restriction is classified by the point during pregnancy when the fetus is 
affected—symmetrical growth restriction begins in early pregnancy, while asymmetrical 
growth restriction is a result of an event in the third trimester, such as preeclampsia.  
Fetuses with asymmetrical growth restriction tend to have a disparity in their length and 
head circumference when compared to body weight. Maternal risk factors for low 
birthweight include poor nutrition, smoking, and drug or alcohol abuse.  Infections such 
as rubella, cytomegalovirus, toxoplasmosis, and syphilis can also lead to low birthweight.  
Chronic renal failure, sickle cell anemia, phenylketonuria, thrombophilia, and 
preeclampsia are all conditions considered to be risk factors for low birthweight.  
Research is beginning to emerge on environmental risk factors for low birthweight.  A 
recent British study found that increased maternal exposure to air pollution, particularly 
sulfur dioxide, was associated with low birthweight prevalence (Bobak 2000). 
Low birthweight data are collected by the MDPH Bureau of Health Information, 
Statistics, Research, and Evaluation (BHISRE) Registry of Vital Records and Statistics.  
The number of low birthweight births for each city and town and the state as a whole are 
available through the Massachusetts Community Health Information Profile (MassCHIP).  
For this analysis, rates were calculated by comparing the number of low birthweight 
babies to the number of total births per community within the time period of 2000-2005.  
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A rate per 10,000 live births was then calculated to allow for easier comparison to the 
state.  A 95% confidence interval (CI) was also calculated for each rate.  As discussed 
earlier, a confidence interval indicates the precision of a rate; the wider the interval, the 
less certain or stable the rate.  Statistically, the width of the interval reflects the size of the 
population and the number of events; smaller populations yield less precise estimates 
which have wider confidence intervals.  The results of the analysis of low birthweight 
data can be seen in Table 7. 
As illustrated in Table 7, both Northampton and Easthampton had prevalence estimates 
for low birthweight births that were statistically significantly lower than the state of 
Massachusetts as a whole.  In the six-year time period analyzed, 46 babies were born in 
Northampton and 48 were born in Easthampton that were considered to be of low 
birthweight.  Because these numbers are relatively small, the calculated prevalence 
estimates produced wide confidence intervals, illustrating their statistical instability.   
However, because the estimates are considerably lower than that of the state, it can 
reasonably be concluded that low birthweight prevalence is not elevated in either 
community.   
IV. ASTHMA SURVEILLANCE  
Asthma prevalence was included as a concern of residents living near the Northampton 
Regional Landfill.  According to the U.S. Centers for Disease Control (CDC) definition, 
asthma is a reversible obstructive lung disease caused by increased reaction of the 
airways to various stimuli (Akinbami 2006). When an individual suffers from asthma, the 
42 
muscles of the airways constrict, causing an interruption in normal breathing.  This 
constriction is a result of an environmental or biological agent which irritates the airway. 
Although there is medical agreement on agents that can trigger asthma, such as cold air, 
allergens, and exposure to fine particles in air pollution, current information in the 
medical literature does not provide firm conclusions about the causes of or risk factors for 
the initial onset of asthma.  Many researchers have sought to identify specific 
environmental exposures associated with the development of asthma.  In a report by the 
National Institute of Medicine for the U.S. Environmental Protection Agency on 
exposures related to both asthma onset and the exacerbation of established asthma, 
exposure to house dust mites was reported to cause asthma onset while exposure to 
environmental tobacco smoke among preschool age children was reported to be 
associated with asthma onset (meaning the weight of the evidence for causation was less 
for environmental tobacco smoke than for house dust mites) (Redd 2002).  It is well-
documented that outdoor exposures to ozone and particulate matter can exacerbate 
asthma.  However, whether outdoor pollution is associated with asthma onset is not yet 
known. 
Children are more likely to be diagnosed with asthma than adults.  Approximately 12.5% 
of children in the US have been diagnosed with asthma (Dey and Bloom 2005).  In the 
last few decades, the prevalence of asthma has increased, especially among children. The 
reason for this increase has yet to be explained.  Male children are more likely to be 
diagnosed with asthma than female children.  This gender inequality changes once 
individuals reach adulthood, when women become more likely than men to develop 
asthma (ALA 2005).  Asthma which occurs in childhood will sometimes resolve before 
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adulthood.  Currently about 7% of the entire U.S. population suffers from asthma, 
however rates in Massachusetts and New England are among the highest in the U.S.   
Statewide pediatric asthma surveillance has been conducted by the BEH for school years 
2003-2004, 2004-2005, 2005-2006, and 2006-2007 (MDPH 2004, 2005a, 2006, 2007).  
As part of a cooperative agreement with the CDC, MDPH’s BEH established a statewide 
tracking system for pediatric asthma. All public and private schools in Massachusetts 
with any grade kindergarten through 8 report the number of enrolled students with a 
diagnosis of asthma.  This information is provided by school nurses and/or administrative 
staff through a standardized report form.  School enrollment data were collected from the 
Massachusetts Department of Education (MDOE) or from a school’s administrative staff.  
Data available from the tracking program indicate that the statewide prevalence of asthma 
among children in grades K through 8 is approximately 10%.   
Table 8 contains prevalence estimates for all of the Northampton K-8 schools that have 
participated in the MDPH pediatric asthma surveillance program.  The prevalence of 
asthma in the Bridge School was statistically significantly higher than the statewide 
prevalence for 3 of the 4 years reported.  At the John F. Kennedy Middle School, asthma 
prevalence was statistically significantly elevated in the first two years of surveillance, 
but not in the subsequent two years.  At the Jackson Street School, asthma prevalence 
was similar to the state as a whole for the first three years of surveillance and then 
statistically significantly elevated in the most recent year of surveillance.  In three 
different schools – the Leeds, the Montessori School of Northampton, and the Solomon 
Schechter Day School – pediatric asthma prevalence was either similar to the state as a 
whole or statistically significantly lower than the statewide prevalence, depending on the 
44 
school year.  For the remaining Northampton K-8 schools, the prevalence of pediatric 
asthma was similar to that of the state as a whole. 
Table 9 contains asthma prevalence estimates for all of the participating Easthampton K-
8 schools.  The prevalence of pediatric asthma in the Center School was statistically 
significantly higher than that of the state as a whole for the years 2005-2006 and 2006-
2007 and at the Neil A. Pepin School for the year 2005-2006.  For the other school years, 
the prevalence of pediatric asthma in both schools was either lower than or consistent 
with the statewide pediatric asthma experience.  The White Brook Middle School had 
statistically significantly lower pediatric asthma prevalence in 2003-2004 and 2004-2005 
than the state as a whole.  For the remaining Easthampton K-8 schools, the prevalence of 
pediatric asthma was similar to that of the state as a whole. 
The Robert K. Finn School on Ryan Road in Northampton is in closest proximity to the 
Northampton Regional Landfill (see Figure 3); it is approximately a mile and a half from 
the Northampton Regional Landfill.  For three school years, 2003-2004, 2004-2005, and 
2005-2006, the prevalence of asthma in the R.K. Finn School was similar (i.e., not 
statistically significantly different) compared to the state as a whole. It ranged from 8.2% 
in the 2005-2006 school year to 10.3% in the 2004-2005 school year.  This is consistent 
with the statewide pediatric asthma prevalence.  In the latest school year of surveillance, 
2006-2007, asthma prevalence was statistically significantly elevated at the R.K. Finn 
School (at approximately 16%).  There are no schools in Easthampton within 2 miles of 
the landfill. 
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Hospital discharge data were also analyzed to assess hospitalizations for asthma-related 
conditions for Northampton and Easthampton.  The Massachusetts Division of Health 
Care Finance and Policy (DHCFP) collects patient-level information on all patients who 
are discharged from hospitals in Massachusetts.  The collection of data is mandated by 
regulation 114.1 CMR 17.00, Requirement for the Submission of Hospital Case Mix and 
Charge Data.  Hospital discharge data are available through the MDPH Massachusetts 
Community Health Information Profile (MassCHIP).  While the MCR collects address at 
diagnosis for each individual in its database, the hospital discharge database does not 
include detailed address information.  Therefore, an aggregate analysis of hospital 
discharge data was possible, providing hospitalization rates at the community-level for 
both Northampton and Easthampton. 
Each hospitalization in Massachusetts is coded using the International Classification of 
Disease 9th Revision codes (ICD-9).  The hospital discharge database of MassCHIP was 
searched using the specific ICD-9 code for asthma-related conditions, where asthma was 
the primary or associated cause of hospitalization for residents of Northampton and 
Easthampton.  
These data were examined to determine how many times individuals from Northampton 
and Easthampton were hospitalized with asthma or an asthma-related condition each year 
during the six-year period of 2000 through 2005.  The statistic reported is the 
Standardized Hospitalization Ratio (SHR).  The SHR is analogous to the SIR in its 
calculation and interpretation.  However, instead of counting individuals diagnosed with 
a given disease, the SHR utilizes the number of hospitalizations for a city or town.  In this 
report, the SHR is the ratio of the number of hospitalizations observed in either 
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Northampton or Easthampton to the number that would be expected if the community’s 
population had the same age-specific hospitalization rates as the statewide population, 
multiplied by 100.  As with an SIR, if the SHR is above 100, this indicates that more 
hospitalizations occurred than where expected.  Similarly, if the SHR is below 100, fewer 
hospitalizations occurred than were expected. 
There are some limitations to the data on asthma-related hospitalizations.  First, unlike 
cancer data that are available at a smaller geographic level (i.e. census tract level), the 
data for hospitalizations are only provided by MassCHIP at the city/town level or the zip 
code level.  This makes it impossible to determine if one area of the city has more 
hospitalizations for a particular condition than another area of the city.  The SHR can be 
used, therefore, to indicate if Northampton or Easthampton is experiencing a higher or 
lower rate of hospitalizations from asthma-related conditions than the state as a whole.  
Another limitation of the hospitalization data is that SHRs are based on the numbers of 
hospitalizations reported, not on the number of individuals hospitalized.  For example, 
when the database is used to identify the number of asthma-related hospitalizations in 
Northampton or Easthampton during a specified time period, it would count one 
individual hospitalized ten times the same number of times as it would count ten 
individuals each hospitalized once.  It is important to keep this information in mind when 
interpreting the hospital discharge data presented in this report.   
The hospital discharge data for asthma-related hospitalizations in Northampton, 
Easthampton, and the state as a whole from 2000-2005 can be seen in Table 10.  With the 
exception of one year in Northampton (2001), there were no statistically significant 
elevations in the Standardized Hospitalization Ratios (SHRs) for asthma-related 
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hospitalizations for residents of either Northampton or Easthampton.  This means that 
rates of hospitalization for asthma and asthma-related conditions were at or near expected 
rates in both communities, based on the statewide experience of hospitalizations for these 
conditions during the same years.  In 2001 in Northampton, 215 asthma-related 
hospitalizations were reported compared to approximately 187 expected; this difference 
was of borderline statistical significance. 
V. CHILDHOOD LEAD POISONING   
As part of this review, childhood lead poisoning data were also reviewed.  Data on 
childhood blood lead levels are available from the MDPH Bureau of Environmental 
Health’s Childhood Lead Poisoning Prevention Program (CLPPP). 
Children exposed to lead through inhalation or ingestion may experience effects on their 
nervous system which could lead to slowed development, learning disabilities, and/or 
behavioral problems.  Lead is a toxic soft metal which is used in construction, batteries, 
and bullets, as well as in solder and many alloys.   It can be found in the environment due 
to its historic and widespread use in industry.  Lead can be present in soil because of 
natural deposits, improper disposal by industry, or leaks from underground leaded 
gasoline tanks.  A 1973 mandate implemented standards to phase out leaded gasoline in 
the United States, and in 1996 it became illegal to use leaded gasoline in an on-road 
vehicle.  These measures helped to decrease blood-lead levels in the U.S.  However, the 
most significant source of children’s exposure relates to lead present in older homes and 
apartments, particularly those built before 1978, due to the use of lead in paint.  
Massachusetts law requires the removal of lead paint hazards in any home built before 
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1978 where children under the age of six live.  Lead hazards include loose lead paint and 
lead paint on windows and other surfaces accessible to children. 
Young children are particularly sensitive to the health effects of lead as they are more 
likely to display hand to mouth behavior, or pica.  This can lead to increased ingestion of 
lead via contaminated paint chips or soil.  The Bureau of Environmental Health’s CLPPP 
manages the prevention, screening, diagnosis, and treatment of lead poisoning among 
children. By regulation, Massachusetts has a universal screening program requiring all 
children ages 1-3 to have their blood lead level analyzed annually and the results must be 
reported to the CLPPP program.  Children who live in communities designated as “high 
risk” are required to have their blood tested for lead through age 4. 
According to the U.S. Centers for Disease Control (CDC), a concentration of 10 
micrograms per deciliter of lead in blood is considered to be a threshold level associated 
with potentially detrimental effects.  A blood lead level below this concentration is 
considered to be a non-case.  In Massachusetts, if a blood lead level falls between 10 and 
15 μg/dL, education and outreach materials are sent to parents to assist in reducing 
potential exposures in the home.  When the level exceeds 15 μg/dL, CLPPP offers case 
management services to the family, and if it exceeds 25 μg/dL, the level defined as lead 
poisoned in Massachusetts, CLPPP must provide case management, monitor medical 
care, and oversee environmental remediation in the home.   
CLPPP screening data were analyzed for Northampton as a whole and CT 8222.00 as 
well as Easthampton as a whole and CT 8224.01.  Percentages of screening tests for 
children in these areas whose blood lead levels fall into the five categories described 
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above are presented in Table 11.  (It should be noted that these percentages are based on 
the number of screening tests performed, not the number of children tested; some 
children undergo multiple tests depending on the levels detected in their blood.)  The 
distribution of screening test results in each CT in the respective communities was 
compared to the community-wide screening test results as well as statewide screening 
results, to assess whether the blood lead levels in children residing in the two census 
tracts containing the Northampton Regional Landfill appear different from the 
communities as a whole or the state as a whole.   
The majority of children screened in the four geographic areas examined fall into the less 
than 10 ug/dL category.  For Northampton, the distribution of blood lead level screening 
tests results is similar (but slightly lower) in CT 8222.00 as for the city as a whole or the 
state as a whole.  For Easthampton, CT 8224.01 had consistently lower blood lead levels 
than the town as a whole and the state as whole.  Therefore, it appears that children living 
in the census tract containing the Northampton Regional Landfill, and children in the 
Easthampton census tract bordering the Landfill, have blood lead levels similar to the 
communities of Northampton and Easthampton as a whole as well as the state. 
CAP also evaluated the geographic distribution of residences of those children in both 
communities with blood lead screening tests results that exceeded 10 ug/dL.  Their 
residential addresses were geocoded and the spatial distribution of their residences was 
examined using Geographic Information System (GIS) software.  The patterns followed 
the population density patterns within each community, indicating that there is no 
particular area in either Northampton or Easthampton that appears to be experiencing a 
higher prevalence of blood lead levels that exceed the CDC threshold level.   
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VI. AUTISM 
Massachusetts does not have a population-based registry for learning disabilities or 
developmental disorders such as autism.  This means that there is no coordinated or 
systematic reporting on these disabilities, and as such, there is no way to estimate with 
precision the incidence or prevalence of such conditions, or whether they are occurring 
more frequently than might be expected in Northampton, Easthampton, or any other 
Massachusetts community.  However, the Massachusetts Department of Education 
(MDOE) began collecting special education enrollment data on an individual level in late 
2001.  Using MDOE data, the BEH Environmental Epidemiology Program (EEP) issued 
a report in December 2005 on the estimated prevalence of autism in school districts 
across the state (MDPH 2005b).  The report is entitled Prevalence Estimates of Autism 
and Autism Spectrum Disorder in Massachusetts – Final Report.  Autism is a pervasive 
developmental disorder characterized by neurobehavioral traits including social 
disability, communication impairment, repetitive behaviors, and restricted interest. These 
prevalence estimates were based on educationally categorized reports of autism as 
recorded in a student’s Individualized Education Program (IEP) plan prepared by special 
education departments in municipalities across the Commonwealth.  While IEP data 
provide an estimate of autism prevalence in Massachusetts schools, they do not account 
for all diagnoses within the autism spectrum. 
In its 2005 report, MDPH reported that the range of prevalence estimates for autism in 
Massachusetts, using statewide totals and IEP data, was 41 to 55 cases per 10,000 
children, depending upon the school year (MDPH 2005b).  The estimates were based on 
enrollment data from the three school years of 2002-2003, 2003-2004, and 2004-2005. 
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Autism counts and school enrollment totals include all students who are enrolled either at 
a public school, private school, collaborative, or out-of-state educational placement and 
receive some public funding for their special educational services from their home 
district.  Not included in school enrollment are private school students who do not receive 
public funds to attend their school and children who are home-schooled.   
For Northampton, Easthampton, and the state as a whole, autism prevalence estimates are 
presented in Table 12.  In Northampton, the prevalence of autism was lower than that of 
the state as a whole during 2002-2003, higher during 2003-2004, and then lower in 2004-
2005.  In Easthampton, the prevalence of autism was higher than that of the state in each 
of the three years reported.  However, for both Northampton and Easthampton, the 
prevalence estimates are not statistically significantly different from those for the state, 
meaning that they most likely represent natural or random variation in autism prevalence.  
Also, it is important to note that the prevalence estimates for both Northampton and 
Easthampton are relatively unstable, as indicated by their relatively large confidence 
intervals.  In Northampton and Easthampton, between 10 and 14 and 9 and 14 students, 
respectively, were reported to have autism during the three school years for which data 
were reported.   
VII.  DISCUSSION  
According to ACS statistics, cancer is the second leading cause of death in Massachusetts 
and the United States.  Not only will one out of three women and one out of two men 
develop cancer in their lifetime, but cancer will affect three out of every four families.  
For this reason, cancers often appear to occur in “clusters,” and it is understandable that 
52 
someone may perceive that there are an unusually high number of cancer cases in their 
neighborhood or town.  Upon close examination, many of these “clusters” are not 
unusual increases, as first thought, but are related to such factors as local population 
density, variations in reporting or chance fluctuations in occurrence.  In other instances, 
the “cluster” in question includes a high concentration of individuals who possess related 
behaviors or risk factors for cancer.  Some, however, are unusual; that is, they represent a 
true excess of cancer in a workplace, a community, or among a subgroup of people.  A 
suspected cluster is more likely to be a true cancer cluster if it involves a large number of 
cases of one type of cancer diagnosed in a relatively short time period rather than several 
different types diagnosed over a long period of time (i.e., 20 years), a rare type of cancer 
rather than common types, and/or a large number of cases diagnosed among individuals 
in age groups not usually affected by that cancer.  These types of clusters may warrant 
further public health investigation. 
Descriptive epidemiological analyses such as this can be useful in evaluating cancer 
patterns in a geographic context, assessing if a common cause or etiology is possible, and 
serving to identify areas where further public health investigations or actions may be 
warranted.  This descriptive analysis of cancer incidence data alone cannot be used to 
establish a causal link between a particular risk factor (either environmental or non-
environmental) and the development of cancer.  In addition, this analysis cannot 
determine the cause of any one individual’s cancer diagnosis.  The purpose of this 
evaluation was to report on the patterns of certain types of cancer in the communities of 
Northampton and Easthampton and two of the census tracts closest to the Northampton 
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Regional Landfill (CT 8222.00 in Northampton and CT 8224.01 in Easthampton) to 
determine whether such patterns appear unusual.   
Based on the information reviewed in this report, there does not seem to be an atypical 
pattern of the cancer types evaluated in Northampton, Easthampton, in either of the two 
CTs (8222.00 in Northampton or 8224.01 in Easthampton), or in the one-mile radius 
surrounding the Northampton Regional Landfill.  As mentioned previously, the nine 
cancer types evaluated were chosen based on potential associations with contaminants of 
concern at the Northampton Regional Landfill and/or residents’ concerns over suspected 
elevations of some cancer types.  Although there were elevations in some cancer types 
during certain time periods, in most instances, the elevations represented one or two 
additional diagnoses of a particular type of cancer over what would be expected and the 
differences were not statistically significant, meaning that they could be due to chance 
and represent natural variability in rates.   
Although there were three types of cancer in Northampton that were statistically 
significantly elevated in one time period – kidney cancer in females in Northampton 
during 1997-2004, leukemia in females in Northampton CT 8222.00 during 1992-1996, 
and breast cancer in females in Northampton in 1997-2004 (including CT 8222.00) – 
these cancer types were not elevated during the other three time periods evaluated.  A 
review of risk factor information for Northampton females diagnosed with kidney cancer 
during the last time period evaluated showed that their ages at diagnosis and kidney 
cancer subtypes were consistent with what would be expected based on the 
epidemiological literature, and that smoking and occupation could have contributed to the 
incidence of this cancer type.  In addition, MDPH accessed the MCR database to assess 
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the number of new kidney cancer diagnoses in Northampton for the years 2005 to the 
present, and learned that the incidence of kidney cancer appears to be about as expected 
in both genders, based on a crude estimation of the number of diagnoses expected.  
Similarly, a review of risk factor information for CT 8222.00 females diagnosed with 
leukemia during 1992-1996 did not show any unusual patterns.  Four of the six women 
were diagnosed with the most common subtype of adult leukemia, acute myeloid 
leukemia (AML).  One woman’s treatment for a previous cancer may have contributed to 
her diagnosis, and smoking may also have contributed to the incidence of this cancer type 
among some women in CT 8222.00.  The geographic distribution of those individuals 
diagnosed with leukemia in CT 8222.00 closely followed the patterns of population 
density in the CT.  
MDPH reviewed cancer staging information for women diagnosed with breast cancer in 
Northampton for the period 1997-2004.  Staging describes the extent of spread of an 
individual’s cancer; from a public health perspective, earlier breast cancer staging reflects 
to some extent whether women are being screened early and regularly for breast cancer. 
In Northampton, approximately 33% of the women diagnosed with breast cancer between 
1997 and 2004 were diagnosed with in-situ (non-invasive) breast cancer compared to 
24% statewide.  In Northampton CT 8222.00, approximately 43% of the women 
diagnosed with breast cancer between 1997 and 2004 were diagnosed with in-situ breast 
cancer.   
According to the ACS and the medical literature, women who have had no children or 
who had their first child after age 30 have a slightly higher breast cancer risk. Having 
multiple pregnancies and becoming pregnant at an early age reduces breast cancer risk. 
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MDPH reviewed data on maternal age at first birth, available through MassCHIP, for 
Northampton. For 1990, 45% of the women in Northampton had their first child at age 30 
or older compared to 28% statewide.  Similarly, for 2006, 54% of the women in 
Northampton had their first child at age 30 or older compared to 39% statewide.  The 
medical literature also reports that women of higher socioeconomic status tend to have a 
higher risk of breast cancer.  According to the 2000 U.S. Census, approximately 49% of 
Northampton women age 25 or older have at least a Bachelor’s or graduate-level degree 
compared to 31% statewide.  The higher than expected breast cancer incidence in 
Northampton, particularly during the latest time period, appears to be in part correlated 
with educational level (a measure of socioeconomic status) as well as maternal age at first 
birth.  
In Easthampton, the incidence of brain and CNS cancer fluctuated in males and females 
over the four time periods evaluated.  None of the differences between the number of 
observed and expected diagnoses were statistically significant, meaning that the 
elevations may very likely represent natural variation in incidence rates.  For the other 
eight cancer types evaluated, any differences noted between the numbers of observed 
diagnoses compared to the numbers expected most likely are due to chance.  Although 
some elevations were noted in CT 8224.01, for three of the eight cancer types during 
different time periods, the elevations did not persist during the other three time periods 
evaluated and were not statistically significant. 
The analysis of the geographic distribution of residence at diagnosis for individuals 
diagnosed with the nine cancer types evaluated in Northampton or Easthampton did not 
reveal any atypical spatial patterns, any patterns that would suggest a common factor 
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(environmental or non-environmental) played a primary role in the incidence of cancer in 
either community during the 23-year time period 1982-2004.  Moreover, no unusual 
concentrations of individuals diagnosed with any of the cancer types were observed in the 
vicinity of the Northampton Regional Landfill.   
Overall, a review of other readily available health outcome data, specifically for 
reproductive outcomes, asthma, and childhood blood lead poisoning, did not show any 
unusual patterns when the experiences of Northampton and Easthampton were compared 
to those of the state as a whole.  While the numbers of children diagnosed with autism in 
Easthampton were consistently higher than the statewide rates, the differences were not 
statistically significant and were based on a small number of diagnoses. 
Although the prevalence estimates of birth defects in Northampton and Easthampton 
were higher than the state, the differences were not statistically significant and the 
evaluation by the MDPH clinical geneticist did not identify any unusual spatial patterns 
or clustering of specific birth defects in either community.  The prevalence of low 
birthweight babies in both communities was statistically significantly lower than the 
statewide prevalence for this outcome.  The prevalence of pediatric asthma in the Robert 
K. Finn School in Northampton, the closest school to the Northampton Landfill, was 
similar to that of the state as a whole for 3 of the 4 years of surveillance.  In the latest 
school year of surveillance, 2006-2007, asthma prevalence was statistically significantly 
elevated at the Finn School.  MDPH followed up with the Northampton school nurse 
leader and Finn School nurse, to determine if there has been a change in reporting or 
enrollment, which might account for the change in prevalence estimates in later years.  
Both nurses felt that better parental reporting is most likely responsible, which can be 
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attributed to changes made to the health and medication forms completed by parents as 
well as an increased awareness of asthma among parents and their willingness to report.  
No elevations were seen among hospital discharge data for asthma-related 
hospitalizations among residents of Northampton or Easthampton, where asthma was the 
primary or secondary cause of admission.  Childhood blood lead levels for the census 
tract containing the Northampton Regional Landfill as well as the Easthampton census 
tract that borders the landfill were consistent with those of the communities of 
Northampton and Easthampton as a whole as well as the state.   
The purpose of this review of readily-available health outcome data was to assess if there 
were any unusual patterns of health outcomes in either Northampton or Easthampton or 
the census tracts containing the Northampton Regional Landfill.  The health outcomes 
examined vary in nature and have different risk factors.  This type of descriptive 
epidemiologic investigation serves as a screening-level assessment that can be used to 
determine the need for future public health actions.   
VIII. CONCLUSIONS AND RECOMMENDATIONS 
 
Overall, a review of cancer incidence data and other readily available health outcome 
data did not reveal any unusual patterns in either Northampton or Easthampton, in the 
census tracts in closest proximity to the Northampton Regional Landfill, or in the one-
mile radius surrounding the Northampton Regional Landfill.  While some exceptions 
were noted, when a particular incidence rate or the prevalence of a particular health 
outcome was higher than the statewide rate, the elevations did not persist over time and 
when examined closely, no unusual patterns emerged with respect to their spatial or 
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temporal distribution or available risk factor information.  The MDPH/BEH will continue 
to monitor the incidence of cancer in the city of Northampton and town of Easthampton 
through the Massachusetts Cancer Registry and, as a separate effort, review and evaluate 
environmental sampling data to assess potential public health impacts. 
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Cancer Type
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder1 19 29.1 65 39  -- 102 14 20.5 68 37  -- 115 5 8.7 57 19  -- 135
Brain and CNS2 5 13.8 36 * 12  -- 84 3 6.3 NC NC  -- NC 2 7.5 NC NC  -- NC
Breast1 112 94.1 119 98  -- 143 0 0.6 NC NC  -- NC 112 93.5 120 99  -- 144
Hodgkin lymphoma 6 5.9 103 37  -- 223 4 2.8 NC NC  -- NC 2 3.1 NC NC  -- NC
Kidney 14 11.6 121 66  -- 202 10 6.8 147 70  -- 269 4 4.8 NC NC  -- NC
Leukemia 9 12.7 71 32  -- 134 6 6.8 88 32  -- 192 3 6.0 NC NC  -- NC
Liver and Intrahepatic Bile Ducts 0 3.1 NC NC  -- NC 0 2.0 NC NC  -- NC 0 1.1 NC NC  -- NC
Lung and Bronchus 74 89.1 83 65  -- 104 45 58.2 77 56  -- 103 29 30.9 94 63  -- 135
Non-Hodgkin lymphoma 25 19.6 128 83  -- 189 12 9.6 125 65  -- 219 13 10.0 130 69  -- 223
1 Includes In situ and Invasive cancers
2 Includes Benign and Malignant tumors
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI 95% CI 95% CI
TABLE 1A
Cancer Incidence
Northampton, Massachusetts
1982-1986
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Cancer Type
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder1 22 27.4 80 50  -- 122 11 19.5 57 28  -- 101 11 7.9 139 69  -- 248
Brain and CNS2 13 14.7 88 47  -- 151 9 6.7 135 62  -- 256 4 8.0 NC NC  -- NC
Breast1 111 108.0 103 85  -- 124 1 0.7 NC NC  -- NC 110 107.3 103 84  -- 124
Hodgkin lymphoma 5 6.2 81 26  -- 189 2 2.9 NC NC  -- NC 3 3.3 NC NC  -- NC
Kidney 17 15.5 110 64  -- 176 11 9.3 118 59  -- 211 6 6.1 98 36  -- 213
Leukemia 3 12.0 NC NC  -- NC 3 6.5 NC NC  -- NC 0 5.5 NC NC  -- NC
Liver and Intrahepatic Bile Ducts 4 3.6 NC NC  -- NC 4 2.4 NC NC  -- NC 0 1.2 NC NC  -- NC
Lung and Bronchus 77 93.8 82 65  -- 103 48 56.9 84 62  -- 112 29 36.8 79 53  -- 113
Non-Hodgkin lymphoma 18 23.5 77 45  -- 121 11 11.8 94 47  -- 168 7 11.8 59 24  -- 122
1 Includes In situ and Invasive cancers
2 Includes Benign and Malignant tumors
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
TABLE 1B
Cancer Incidence
Northampton, Massachusetts
1987-1991
Total Males Females
95% CI 95% CI 95% CI
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Cancer Type
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder1 33 37.8 87 60  -- 123 19 26.6 71 43  -- 111 14 11.2 125 68  -- 210
Brain and CNS2 8 14.5 55 24  -- 109 4 6.8 NC NC  -- NC 4 7.6 NC NC  -- NC
Breast1 141 135.8 104 87  -- 122 0 1.0 NC NC  -- NC 141 134.8 105 88  -- 123
Hodgkin lymphoma 8 5.6 144 62  -- 284 4 2.8 NC NC  -- NC 4 2.7 NC NC  -- NC
Kidney 12 16.7 72 37  -- 126 5 10.0 50 16  -- 116 7 6.6 105 42  -- 217
Leukemia 15 14.2 106 59  -- 174 6 7.6 79 29  -- 173 9 6.6 136 62  -- 258
Liver and Intrahepatic Bile Ducts 0 4.7 NC NC  -- NC 0 3.1 NC NC  -- NC 0 1.5 NC NC  -- NC
Lung and Bronchus 84 97.4 86 69  -- 107 49 54.9 89 66  -- 118 35 42.5 82 57  -- 115
Non-Hodgkin lymphoma 23 27.5 84 53  -- 125 9 14.0 64 29  -- 122 14 13.6 103 56  -- 173
1 Includes In situ and Invasive cancers
2 Includes Benign and Malignant tumors
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
TABLE 1C
Cancer Incidence
Northampton, Massachusetts
1992-1996
Total Males Females
95% CI 95% CI 95% CI
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Cancer Type
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder1 70 66.6 105 82  -- 133 42 47.3 89 64  -- 120 28 19.3 145 97  -- 210
Brain and CNS2 15 32.4 46 * 26  -- 76 6 13.8 43 * 16  -- 95 9 18.6 49 * 22  -- 92
Breast1 285 250.3 114 * 101  -- 128 0 1.6 NC NC  -- NC 285 248.7 115 * 102  -- 129
Hodgkin lymphoma 7 8.5 83 33  -- 171 4 3.9 NC NC  -- NC 3 4.5 NC NC  -- NC
Kidney 42 32.3 130 94  -- 176 19 19.2 99 60  -- 154 23 13.0 176 * 112  -- 265
Leukemia 20 28.8 70 42  -- 107 13 15 87 46  -- 148 7 13.8 51 20  -- 105
Liver and Intrahepatic Bile Ducts 7 12.9 54 22  -- 112 5 9.0 55 18  -- 129 2 3.8 NC NC  -- NC
Lung and Bronchus 175 175.8 100 85  -- 115 88 90 98 78  -- 120 87 85.8 101 81  -- 125
Non-Hodgkin lymphoma 42 49.1 85 62  -- 116 22 24.3 90 57  -- 137 20 24.8 81 49  -- 125
1 Includes In situ and Invasive cancers
2 Includes Benign and Malignant tumors
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
TABLE 1D
Cancer Incidence
Northampton, Massachusetts
1997-2004
Total Males Females
95% CI 95% CI 95% CI
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Cancer Type
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder1 4 4.0 NC NC  -- NC 4 3.0 NC NC  -- NC 0 1.1 NC NC  -- NC
Brain and CNS2 1 2.3 NC NC  -- NC 0 1.1 NC NC  -- NC 1 1.2 NC NC  -- NC
Breast1 13 14.3 85 48  -- 155 0 0.1 NC NC  -- NC 13 14.2 92 49  -- 156
Hodgkin lymphoma 2 1.0 NC NC  -- NC 1 0.6 NC NC  -- NC 1 0.4 NC NC  -- NC
Kidney 5 1.8 282 91  -- 659 4 1.1 NC NC  -- NC 1 0.7 NC NC  -- NC
Leukemia 1 2.0 NC NC  -- NC 1 1.1 NC NC  -- NC 0 0.8 NC NC  -- NC
Liver and Intrahepatic Bile Ducts 0 0.4 NC NC  -- NC 0 0.3 NC NC  -- NC 0 0.1 NC NC  -- NC
Lung and Bronchus 10 13.4 75 36  -- 138 8 8.8 91 39  -- 179 2 4.5 NC NC  -- NC
Non-Hodgkin lymphoma 5 2.9 171 55  -- 398 3 1.6 NC NC  -- NC 2 1.3 NC NC  -- NC
1 Includes In situ and Invasive cancers
2 Includes Benign and Malignant tumors
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
TABLE 2A
Cancer Incidence
Census Tract 8222.00 in Northampton, Massachusetts
1982-1986
Total Males Females
95% CI 95% CI 95% CI
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Cancer Type
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder1 4 3.9 NC NC  -- NC 4 2.8 NC NC  -- NC 0 1.1 NC NC  -- NC
Brain and CNS2 1 2.5 NC NC  -- NC 0 1.2 NC NC  -- NC 1 1.3 NC NC  -- NC
Breast1 23 17.6 131 83  -- 196 1 0.1 NC NC  -- NC 22 17.5 126 79  -- 190
Hodgkin lymphoma 3 1.1 NC NC  -- NC 1 0.6 NC NC  -- NC 2 0.5 NC NC  -- NC
Kidney 2 2.5 NC NC  -- NC 2 1.6 NC NC  -- NC 0 0.9 NC NC  -- NC
Leukemia 0 1.9 NC NC  -- NC 0 1.1 NC NC  -- NC 0 0.8 NC NC  -- NC
Liver and Intrahepatic Bile Ducts 0 0.6 NC NC  -- NC 0 0.4 NC NC  -- NC 0 0.2 NC NC  -- NC
Lung and Bronchus 9 14.5 62 28  -- 118 7 9.0 78 31  -- 160 2 5.5 NC NC  -- NC
Non-Hodgkin lymphoma 1 3.8 NC NC  -- NC 1 2.1 NC NC  -- NC 0 1.7 NC NC  -- NC
1 Includes In situ and Invasive cancers
2 Includes Benign and Malignant tumors
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI 95% CI 95% CI
TABLE 2B
Cancer Incidence
Census Tract 8222.00 in Northampton, Massachusetts
1987-1991
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Cancer Type
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder1 9 6.0 149 68  -- 284 6 4.4 137 50  -- 298 3 1.6 NC NC  -- NC
Brain and CNS2 3 2.7 NC NC  -- NC 1 1.4 NC NC  -- NC 2 1.4 NC NC  -- NC
Breast1 18 25.3 71 42  -- 112 0 0.2 NC NC  -- NC 18 25.1 72 42  -- 113
Hodgkin lymphoma 2 1.1 NC NC  -- NC 2 0.6 NC NC  -- NC 0 0.4 NC NC  -- NC
Kidney 2 3.0 NC NC  -- NC 2 1.9 NC NC  -- NC 0 1.1 NC NC  -- NC
Leukemia 7 2.5 277 * 111  -- 571 1 1.4 NC NC  -- NC 6 1.1 555 * 203  -- 1208
Liver and Intrahepatic Bile Ducts 0 0.8 NC NC  -- NC 0 0.6 NC NC  -- NC 0 0.2 NC NC  -- NC
Lung and Bronchus 13 16.5 79 42  -- 134 7 9.7 72 29  -- 149 6 6.9 87 32  -- 190
Non-Hodgkin lymphoma 5 4.8 104 33  -- 242 2 2.7 NC NC  -- NC 3 2.1 NC NC  -- NC
1 Includes In situ and Invasive cancers
2 Includes Benign and Malignant tumors
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI 95% CI 95% CI
TABLE 2C
Cancer Incidence
Census Tract 8222.00 in Northampton, Massachusetts
1992-1996
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Cancer Type
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder1 12 12.2 98 51  -- 172 8 9.0 89 38  -- 175 4 3.2 NC NC  -- NC
Brain and CNS2 4 6.7 NC NC  -- NC 1 3.1 NC NC  -- NC 3 3.6 NC NC  -- NC
Breast1 68 52.9 128 * 100  -- 163 0 0.3 NC NC  -- NC 68 52.6 129 * 101  -- 164
Hodgkin lymphoma 1 1.6 NC NC  -- NC 1 0.9 NC NC  -- NC 0 0.7 NC NC  -- NC
Kidney 12 6.6 183 94  -- 320 8 4.1 194 84  -- 383 4 2.4 NC NC  -- NC
Leukemia 4 5.5 NC NC  -- NC 4 3.1 NC NC  -- NC 0 2.4 NC NC  -- NC
Liver and Intrahepatic Bile Ducts 1 2.6 NC NC  -- NC 1 2.0 NC NC  -- NC 0 0.6 NC NC  -- NC
Lung and Bronchus 38 33.2 114 81  -- 157 17 17.9 95 55  -- 152 21 15.4 136 85  -- 209
Non-Hodgkin lymphoma 9 9.4 96 44  -- 182 5 5.1 99 32  -- 231 4 4.3 NC NC  -- NC
1 Includes In situ and Invasive cancers
2 Includes Benign and Malignant tumors
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI 95% CI 95% CI
TABLE 2D
Cancer Incidence
Census Tract 8222.00 in Northampton, Massachusetts
1997-2004
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Cancer Type
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder1 12 14.1 85 44  -- 148 7 10.2 68 27  -- 141 5 3.9 128 41  -- 299
Brain and CNS2 11 7.2 152 76  -- 272 6 3.5 172 63  -- 375 5 3.8 133 43  -- 310
Breast1 44 47.1 93 68  -- 125 1 0.3 NC NC  -- NC 43 46.8 92 66  -- 124
Hodgkin lymphoma 3 2.8 NC NC  -- NC 1 1.6 NC NC  -- NC 2 1.3 NC NC  -- NC
Kidney 10 5.9 168 81  -- 310 4 3.6 NC NC  -- NC 6 2.4 253 93  -- 551
Leukemia 5 6.4 78 25  -- 183 4 3.6 NC NC  -- NC 1 2.8 NC NC  -- NC
Liver and Intrahepatic Bile Ducts 0 1.5 NC NC  -- NC 0 1.0 NC NC  -- NC 0 0.5 NC NC  -- NC
Lung and Bronchus 42 46.2 91 66  -- 123 27 30.1 90 59  -- 130 15 16.0 94 52  -- 155
Non-Hodgkin lymphoma 7 9.7 72 29  -- 149 5 5.0 100 32  -- 233 2 4.7 NC NC  -- NC
1 Includes In situ and Invasive cancers
2 Includes Benign and Malignant tumors
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI 95% CI 95% CI
TABLE 3A
Cancer Incidence
Easthampton, Massachusetts
1982-1986
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Cancer Type
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder1 12 14.0 86 44  -- 150 9 10.3 87 40  -- 166 3 3.7 NC NC  -- NC
Brain and CNS2 11 7.8 141 70  -- 252 7 3.8 185 74  -- 382 4 4.0 NC NC  -- NC
Breast1 50 55.9 89 66  -- 118 0 0.4 NC NC  -- NC 50 55.5 90 67  -- 119
Hodgkin lymphoma 3 3.0 NC NC  -- NC 2 1.6 NC NC  -- NC 1 1.4 NC NC  -- NC
Kidney 6 8.3 73 26  -- 158 5 5.1 98 31  -- 228 1 3.2 NC NC  -- NC
Leukemia 4 6.2 NC NC  -- NC 2 3.6 NC NC  -- NC 2 2.6 NC NC  -- NC
Liver and Intrahepatic Bile Ducts 3 1.9 NC NC  -- NC 3 1.3 NC NC  -- NC 0 0.6 NC NC  -- NC
Lung and Bronchus 40 51.0 78 56  -- 107 22 31.4 70 44  -- 106 18 19.6 92 54  -- 145
Non-Hodgkin lymphoma 11 12.1 91 45  -- 163 4 6.4 NC NC  -- NC 7 5.7 123 49  -- 254
1 Includes In situ and Invasive cancers
2 Includes Benign and Malignant tumors
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI 95% CI 95% CI
TABLE 3B
Cancer Incidence
Easthampton, Massachusetts
1987-1991
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Cancer Type
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder1 16 20.4 79 45  -- 128 11 14.7 75 37  -- 134 5 5.6 89 29  -- 207
Brain and CNS2 4 8.1 NC NC  -- NC 1 3.9 NC NC  -- NC 3 4.1 NC NC  -- NC
Breast1 64 73.6 87 70  -- 111 0 0.6 NC NC  -- NC 64 73.0 88 68  -- 112
Hodgkin lymphoma 4 2.9 NC NC  -- NC 3 1.7 NC NC  -- NC 1 1.3 NC NC  -- NC
Kidney 10 9.3 107 51  -- 197 6 5.7 104 38  -- 227 4 3.6 NC NC  -- NC
Leukemia 6 7.7 78 28  -- 169 5 4.3 115 37  -- 269 1 3.4 NC NC  -- NC
Liver and Intrahepatic Bile Ducts 2 2.6 NC NC  -- NC 2 1.8 NC NC  -- NC 0 0.8 NC NC  -- NC
Lung and Bronchus 58 54.5 106 81  -- 138 29 31.1 93 63  -- 134 29 23.4 124 83  -- 178
Non-Hodgkin lymphoma 7 14.9 47 * 19  -- 97 4 7.9 NC NC  -- NC 3 7.0 NC NC  -- NC
1 Includes In situ and Invasive cancers
2 Includes Benign and Malignant tumors
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI 95% CI 95% CI
TABLE 3C
Cancer Incidence
Easthampton, Massachusetts
1992-1996
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Cancer Type
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder1 30 38.0 79 53  -- 113 24 27.4 88 56  -- 130 6 10.6 57 21  -- 123
Brain and CNS2 23 18.4 125 79  -- 187 8 8.2 97 42  -- 192 15 10.2 147 82  -- 242
Breast1 138 142.4 97 81  -- 114 1 0.9 NC NC  -- NC 137 141.5 97 81  -- 114
Hodgkin lymphoma 5 4.4 113 37  -- 265 3 2.4 NC NC  -- NC 2 2.0 NC NC  -- NC
Kidney 18 18.6 97 57  -- 153 13 11.2 116 62  -- 198 5 7.4 68 22  -- 158
Leukemia 16 16.2 99 56  -- 160 9 8.8 102 47  -- 194 7 7.4 95 38  -- 195
Liver and Intrahepatic Bile Ducts 7 7.4 95 38  -- 196 6 5.3 113 41  -- 246 1 2.1 NC NC  -- NC
Lung and Bronchus 92 101.4 91 73  -- 111 59 52.2 113 86  -- 146 33 49.1 67 * 46  -- 94
Non-Hodgkin lymphoma 32 28.0 114 78  -- 162 17 14.3 119 69  -- 191 15 13.7 109 61  -- 181
1 Includes In situ and Invasive cancers
2 Includes Benign and Malignant tumors
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
TABLE 3D
Cancer Incidence
Easthampton, Massachusetts
1997-2004
Total Males Females
95% CI 95% CI 95% CI
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Cancer Type
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder1 5 7.7 65 21  -- 151 2 5.7 NC NC  -- NC 3 2.0 NC NC  -- NC
Brain and CNS2 8 4.3 185 80  -- 365 4 2.1 NC NC  -- NC 4 2.2 NC NC  -- NC
Breast1 23 26.4 87 55  -- 131 0 0.2 NC NC  -- NC 23 26.2 88 56  -- 131
Hodgkin lymphoma 2 1.9 NC NC  -- NC 0 1 NC NC  -- NC 2 0.8 NC NC  -- NC
Kidney 7 3.4 206 82  -- 423 3 2.1 NC NC  -- NC 4 1.3 NC NC  -- NC
Leukemia 4 3.8 NC NC  -- NC 3 2.2 NC NC  -- NC 1 1.6 NC NC  -- NC
Liver and Intrahepatic Bile Ducts 0 0.9 NC NC  -- NC 0 0.6 NC NC  -- NC 0 0.3 NC NC  -- NC
Lung and Bronchus 22 25.9 85 53  -- 129 14 17.1 82 45  -- 137 8 8.8 91 39  -- 180
Non-Hodgkin lymphoma 6 5.5 109 40  -- 237 4 3 NC NC  -- NC 2 2.6 NC NC  -- NC
1 Includes In situ and Invasive cancers
2 Includes Benign and Malignant tumors
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI
† The CT in Easthampton in closest proximity to the Northampton Regional Landfill during this time period was CT 8224.  In the 1990 U.S. Census, Easthampton CT 8224 was split into two CTs: 8224.01 and 8224.02.  CT 8224.01 is 
the closer of the two CTs to the landfill.  
TABLE 4A
Cancer Incidence
Census Tract 8224† in Easthampton, Massachusetts
1982-1986
Total Males Females
95% CI
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Cancer Type
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder1 6 7.8 77 28  -- 167 3 5.8 NC NC  -- NC 3 2.0 NC NC  -- NC
Brain and CNS2 8 4.8 168 72  -- 331 6 2.4 253 92  -- 551 2 2.4 NC NC  -- NC
Breast1 33 32.6 101 70  -- 142 0 0.2 NC NC  -- NC 33 32.4 102 70  -- 143
Hodgkin lymphoma 1 2.0 NC NC  -- NC 0 1.1 NC NC  -- NC 1 0.9 NC NC  -- NC
Kidney 5 4.8 103 33  -- 241 4 3.1 NC NC  -- NC 1 1.8 NC NC  -- NC
Leukemia 2 3.7 NC NC  -- NC 1 2.2 NC NC  -- NC 1 1.5 NC NC  -- NC
Liver and Intrahepatic Bile Ducts 3 1.1 NC NC  -- NC 3 0.8 NC NC  -- NC 0 0.3 NC NC  -- NC
Lung and Bronchus 22 29.5 75 47  -- 113 10 18.5 54 26  -- 100 12 11.0 109 56  -- 190
Non-Hodgkin lymphoma 5 7.2 70 22  -- 163 2 4.0 NC NC  -- NC 3 3.2 NC NC  -- NC
1 Includes In situ and Invasive cancers
2 Includes Benign and Malignant tumors
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI
† The CT in Easthampton in closest proximity to the Northampton Regional Landfill during this time period was CT 8224.  In the 1990 U.S. Census, Easthampton CT 8224 was split into two CTs: 8224.01 and 8224.02.  CT 8224.01 is 
the closer of the two CTs to the landfill.  
TABLE 4B
Cancer Incidence
Census Tract 8224†  in Easthampton, Massachusetts
1987-1991
Total Males Females
95% CI
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Cancer Type
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder1 7 4.9 143 57  -- 295 4 3.6 NC NC  -- NC 3 1.3 NC NC  -- NC
Brain and CNS2 3 2.4 NC NC  -- NC 1 1.2 NC NC  -- NC 2 1.2 NC NC  -- NC
Breast1 20 21.8 92 56  -- 142 0 0.1 NC NC  -- NC 20 21.7 92 56  -- 143
Hodgkin lymphoma 1 0.9 NC NC  -- NC 1 0.5 NC NC  -- NC 0 0.4 NC NC  -- NC
Kidney 2 2.5 NC NC  -- NC 1 1.6 NC NC  -- NC 1 0.9 NC NC  -- NC
Leukemia 2 2.1 NC NC  -- NC 2 1.2 NC NC  -- NC 0 0.9 NC NC  -- NC
Liver and Intrahepatic Bile Ducts 0 0.7 NC NC  -- NC 0 0.5 NC NC  -- NC 0 0.2 NC NC  -- NC
Lung and Bronchus 17 13.8 123 72  -- 197 12 7.9 152 78  -- 265 5 5.9 84 27  -- 197
Non-Hodgkin lymphoma 0 4.0 NC NC  -- NC 0 2.3 NC NC  -- NC 0 1.8 NC NC  -- NC
1 Includes In situ and Invasive cancers
2 Includes Benign and Malignant tumors
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI
†  In the 1990 U.S. Census, Easthampton CT 8224 was split into two CTs: 8224.01 and 8224.02.  The CT in closest proximity to the Northampton Regional Landfill during this time period was CT 8224.01. 
TABLE 4C
Cancer Incidence
Census Tract 8224.01†  in Easthampton, Massachusetts
1992-1996
Total Males Females
95% CI
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Cancer Type
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder1 10 10.5 95 45  -- 175 9 7.7 116 53  -- 221 1 2.8 NC NC  -- NC
Brain and CNS2 5 6.0 83 27  -- 195 3 2.7 NC NC  -- NC 2 3.3 NC NC  -- NC
Breast1 47 47.9 98 72  -- 130 0 0.3 NC NC  -- NC 47 47.6 99 73  -- 131
Hodgkin lymphoma 2 1.4 NC NC  -- NC 1 0.8 NC NC  -- NC 1 0.6 NC NC  -- NC
Kidney 7 5.8 120 48  -- 247 4 3.6 NC NC  -- NC 3 2.2 NC NC  -- NC
Leukemia 5 4.7 106 34  -- 248 5 2.7 187 60  -- 437 0 2.0 NC NC  -- NC
Liver and Intrahepatic Bile Ducts 1 2.3 NC NC  -- NC 1 1.7 NC NC  -- NC 0 0.6 NC NC  -- NC
Lung and Bronchus 26 29 90 59  -- 131 15 15.3 98 55  -- 162 11 13.6 81 40  -- 144
Non-Hodgkin lymphoma 8 8.2 97 42  -- 191 4 4.4 NC NC  -- NC 4 3.8 NC NC  -- NC
1 Includes In situ and Invasive cancers
2 Includes Benign and Malignant tumors
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
†  In the 1990 U.S. Census, Easthampton CT 8224 was split into two CTs: 8224.01 and 8224.02.  The CT in closest proximity to the Northampton Regional Landfill during this time period was CT 8224.01. 
Total Males Females
95% CI 95% CI 95% CI
TABLE 4D
Cancer Incidence
Census Tract 8224.01†  in Easthampton, Massachusetts
1997-2004
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Table 5:
Streets Included in the One-Mile Radius Surrounding the Northampton Regional Landfill:
Northampton: Easthampton:
Bayberry Lane
Brisson Drive
Drury Lane
Easthampton Road
Farms Road
Glendale Road
Ladyslipper Lane
Loudville Road
Oliver Street
Park Hill
Pine Valley Road
Ryan Road
Sovereign Way
Sylvan Lane
Tiffany Lane
Unnamed Street
Westhampton Road
Woodland Drive
Ashley Circle
Clark Lane
Loudville Road
Oliver Street
Park Hill Road
Pine Hill Road
Russell Lane
Torrey Street
Torrey Way
Upland Meadow Way
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2000-2003 # Rate*
Northampton 16 186.1 106.3 302.1
Easthampton 12 177.5 91.7 310.1
MA 4813 148.8 144.7 153.1
*Rate per 10,000 live births
Table 6: Birth Defect Prevalence Rates: 
Northampton/Easthampton Compared to Massachusetts, 2000-
2003
CIs
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2000-2005 # Rate**
Northampton 46 360 260.3 457.3
Easthampton 48 490 358.3 645.8
MA 35,853 750 742.52 757.48
*Low Birth Weight is considered to be below 2500 grams (5 lbs.) 
**Rate per 10,000 births
Table 7: Low Birth Weight* Prevalence Rates: 
Northampton/Easthampton Compared to Massachusetts, 2000-
2005
CIs
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2003-2004 2004-2005 2005-2006 2006-2007
Northampton Schools
Bridge Street 15.6 (11.6-19.6)* 13.7 (9.8-17.6) 15 (11.0-19.0)* 16.0 (11.8-20.3)*
Jackson Street 11.5 (8.0-15.0) 8.4 (5.5-11.3) 13.7 (10.2-17.3) 18.2 (14.2-22.2)*
Leeds 5.2 (2.9-7.6)* 8.3 (5.3-11.3) 7.4 (4.6-10.2)* 11.4 (7.9-14.8)
Robert K Finn 9.7 (6.3-13.1) 10.3 (6.8-13.9) 8.2 (5.0-11.4) 15.8 (11.4-20.2)*
John F Kennedy Jr High 14.5 (11.9-17.0)* 14.6 (12.1-17.1)* 11.8 (9.4-14.2) 11.1 (8.7-13.5)
Clarke School for the Deaf 9.5 (2.3-16.8) 16.4 (7.1-25.7) 7.3 (0.4-14.1) 16.4 (6.6-26.1)
Montessori School of Northampton n/r 3.7 (0.0-8.7)* 8.5 (0.5-16.5) 8.3 (0.51-16.1)
Smith College Campus School 11.4 (7.6-15.2) n/r 9.4 (5.9-12.8) 10.4 (6.8-14.0)
Solomon Schechter Day School n/r 4.1 (0.2-8.0)* 6.3 (1.4-11.1) 6.4 (0.97-11.8)
Community Prevalence 11.5 (10.2-13.0)* 11.6 (10.3-12.9)* 10.8 (9.6-12.0) n/a
Statewide Prevalence 9.5 (9.4-9.6) 10 (9.9-10.1) 10.6 (10.5-10.7) 10.8 (10.7-10.8)
n/r = not reported; n/a = not available
*indicates a statistically significant difference from the state rate for that school year
Schools with enrollment < 25 were not included for analysis
Table 8:  Pediatric Asthma Prevalence by School, Northampton
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2003-2004 2004-2005 2005-2006 2006-2007
Easthampton Schools
Center School 7.5 (4.0-11.1) 6.0 (2.7-9.3)* 16.7 (11.4-21.9)* 16.2 (11.0-21.5)*
Maple 8.3 (4.5-12.0) 8.4 (4.7-12.1) 7.5 (4.0-11.1) 11.8 (7.6-16.1)
Neil A Pepin 6.2 (2.6-9.7) 8.0 (4.0-12.0) 18.3 (12.4-24.2)* 15.8 (10.2-21.3)
White Brook Middle School 4.2 (2.6-5.8)* 5.0 (3.2-6.8)* n/r n/r
Calvary Baptist n/r 0 7.9 (0.0-16.5) 5.7 (0-13.4)
Notre Dame- Immaculate Conception 5.9 (1.9-9.8) 0 8.0 (3.5-12.6) 11.7 (5.5-17.8)
Williston Northampton 12.1 (5.4-18.8) 9.8 (3.7-15.9) 13.8 (6.2-21.3) 11.5 (4.4-18.6)
Community Prevalence 5.6 (4.5-6.9)* 5.6 (4.5-6.8)* 12.5 (10.2-14.8) n/a
Statewide Prevalence 9.5 (9.4-9.6) 10 (9.9-10.1) 10.6 (10.5-10.7) 10.8 (10.7-10.8)
n/r = not reported; n/a = not available
*indicates a statistically significant difference from the state rate for that school year
Schools with enrollment < 25 were not included for analysis
Table 9:  Pediatric Asthma Prevalence by School, Easthampton
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Obs Exp SHR Obs Exp SHR
2000 110 98.0 112 92 ⎯ 135 171 176.8 97 83 ⎯ 112
2001 112 104.8 107 88 ⎯ 129 215 187.3 115 100 ⎯ 131
2002 133 113.7 117 98 ⎯ 139 215 202.5 106 92 ⎯ 121
2003 134 130.5 103 86 ⎯ 122 230 231.1 99 87 ⎯ 113
2004 122 132.9 92 76 ⎯ 220 230 235.7 98 85 ⎯ 111
2005 126 140.6 90 75 ⎯ 107 200 248.4 81 70 ⎯ 92
Note: SHRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
**indicates that asthma is the primary or secondary cause of hospitalization
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SHR = Standardized Hospitalization Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
TABLE 10
Asthma-Related** Hospitalization Incidence
Easthampton and Northampton, Massachusetts
2000-2005
Easthampton Northampton
95% CI 95% CI
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Blood Lead Level 
(ug/dL) Count of Tests
Percent of Total 
Tests Count of Tests Percent of Total Tests
<10 6216 86.70% 1541 89.60%
10-14 682 9.50% 120 6.90%
15-19 159 2.20% 30 1.70%
20-24 50 0.70% 12 0.70%
25+ 61 0.80% 16 0.90%
Total: 7168 1719
Blood Lead Level 
(ug/dL) Count of Tests
Percent of Total 
Tests Count of Tests Percent of Total Tests
<10 4412 86.30% 1453 94.70%
10-14 465 9.10% 61 3.90%
15-19 130 2.50% 16 1%
20-24 48 0.90% 0 n/a
25+ 54 1.10% 4 0.20%
Total: 5109 1534
Blood Lead Level 
(ug/dL)
<10
10-14
15-19
20-24
25+
Total:
205725
2281212
* All venous and capillary tests including non-cases, cases, and unconfirmed cases
25707
2601426
87.70%
7.90%
2.40%
1.00%
1.00%
63161
25621
Table 11: Childhood Blood Lead Level Test Results*                                
Northampton, Easthampton,Census Tracts 8222.00, 8224.01, & Massachusetts         
1990-2006
Northampton CT 8222.00
Easthampton CT 8224.01
Massachusetts
Count of Tests Percent of Total Tests
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Autism 
Count
Total 
Enrollment Rate* 95% CI
Autism 
Count
Total 
Enrollment Rate* 95% CI
Autism 
Count
Total 
Enrollment Rate* 95% CI
2002-2003 10 2939 34 (13, 55) 9 1723 52 (18, 86) 4080 991,641 41 (40, 42)
2003-2004 16 3016 53 (27, 79) 14 1663 84 (40, 128) 4876 991,478 49 (48, 51)
2004-2005 14 3024 46 (22, 70) 11 1655 66 (27, 106) 5467 986,662 55 (54, 57)
*Prevalence per 10,000 students based on IEP data and enrollment
Table 12:  Autism Prevalence:  Northampton, Easthampton, & Massachusetts                                 
School Years 2002-2003, 2003-2004, and 2004-2005
Northampton Easthampton Massachusetts
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
APPENDIX A 
Cancer Incidence Coding Definitions
  
APPENDIX A 
ICD CODES USED FOR THIS REPORT 
 
Cancer Site / Type  ICD-O-31 
 Primary Site Codes Histology Type 
Codes2 
   
Urinary Bladder C67.0 - C67.9 
 
all except 9590 - 9989 
 
Brain & Other Nervous System C70.0 - C72.9 
 
all except 9590 - 9989 
 
Breast C50.0 - C50.9 
 
all except 9590 - 9989 
 
Hodgkin Lymphoma 
 
C00.0 - C80.9 
 
includes 9650 – 9667 
 
Kidney & Renal Pelvis C64.9, C65.9 
 
all except 9590 - 9989 
 
Leukemia C00.0 - C80.9 
 
 
 
C42.0, C42.1, C42.4 
 
includes 9733, 9742,     
9800-9820, 9826, 
9831-9948, 9963-9964 
 
includes 9823, 9827 
 
Liver and Intrahepatic Bile 
Ducts 
C22.0, C22.1 
 
all except 9590 - 9989 
 
Lung and Bronchus C34.0 - C34.9 
 
all except 9590 - 9989 
 
Non-Hodgkin('s) 
Lymphoma 
C00.0 - C80.9 
 
 
all sites except C42.0, C42.1, 
C42.4 
 
includes 9590 - 9595, 
9670 – 9729 
 
includes 9823, 9827 
 
 
 
 
 
 
 
 
                                                 
1 International Classification of Diseases for Oncology, 3d Ed. (2) (includes codes added since publication)  
 
2 Except where noted, only invasive cancers (those with invasive behaviors) are included in this report. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX B 
Risk Factor Information for Selected Cancer Types 
Risk Factor Summary for Bladder Cancer 
 
Source: Community Assessment Program, Bureau of Environmental Health, Massachusetts Department of Public Health 
May 2006 
The American Cancer Society estimates that bladder cancer will affect 61,420 people in 
the U.S. in 2006, accounting for 6% of all cancers diagnosed in the United States among 
men and 2% among women.  In Massachusetts, bladder cancer accounts for 
approximately 5% of all cancers diagnosed among males and females combined (ACS 
2006a).  Males are four times more likely to develop bladder cancer than females and 
whites are two times more likely to develop this disease than blacks.  The risk of bladder 
cancer increases with age and nearly 90% of people with this cancer are over the age of 
55 at the time of diagnosis (ACS 2006b). 
The greatest risk factor for bladder cancer is cigarette smoking.  Smokers are more than 
twice as likely to develop bladder cancer compared to nonsmokers (ACS 2006a).  The 
risk of developing bladder cancer increases with the number of packs smoked per day and 
with duration of smoking.  Further, the risk of bladder cancer may be higher in women 
than in men who smoke comparable numbers of cigarettes (Castelao et al. 2001).  
Approximately 25-60% of all bladder cancers can be attributed to tobacco use (Johansson 
and Cohen 1997).  Smoking cessation has been found to reduce the risk of developing 
bladder cancer by 30% to 60% (Silverman et al. 1996). 
Studies have also revealed a number of occupations that are associated with bladder 
cancer.  In fact, exposures to chemicals in the workplace account for an estimated 20-
25% of all bladder cancers diagnosed among men in the U.S. (Johansson and Cohen 
1997).  Occupational exposure to aromatic amines, such as benzidine and beta-
naphthylamine, increases the risk of bladder cancer (ACS 2006b).  These chemicals were 
common in the dye industry in the past.  A higher risk of bladder cancer has also been 
observed among aromatic amine manufacturing workers as well as among workers in the 
rubber, leather, textiles, printing, and paint products industries (ACS 2006a; Silverman et 
al. 1996).  The development of new chemicals, changed worker exposures, and the 
elimination of many known bladder carcinogens in the workplace have caused shifts in 
those occupations considered to be high risk.  For example, risks among dye, rubber, and 
leather workers have declined over time, while other occupations such as motor vehicle 
operation (e.g., drivers of trucks, buses, and taxis) and the aluminum industry have 
emerged as potential high-risk occupations (Silverman et al. 1996).  However, specific 
occupational exposures in these occupations have not been confirmed and study findings 
are not consistent.  Further, the risk of bladder cancer from occupational exposures may 
be increased among smokers (ACS 2006b). 
Dietary factors such as consumption of fried foods as well as foods high in fat and 
cholesterol have been found to be associated with increased bladder cancer risk 
(Silverman et al. 1996).  Use of some anti-cancer drugs (e.g., cyclophosphamide and 
chlornaphazine), use of phenacetin, and infection with Shistosoma haematobium (a 
parasite found in Africa) are thought to be associated with the development of bladder 
cancer.  However, not all epidemiological studies have produced convincing findings 
(Silverman et al. 1996). 
Other risk factors for bladder cancer include a personal history of bladder cancer, certain 
rare birth defects involving the bladder, and exposure to ionizing radiation (ACS 2006a; 
Silverman et al. 1996).  Long term exposure to chlorinated by-products in drinking water 
Risk Factor Summary for Bladder Cancer 
 
Source: Community Assessment Program, Bureau of Environmental Health, Massachusetts Department of Public Health 
May 2006 
has also been suggested to increase the risk of developing bladder cancer, particularly 
among men (Villanueva 2003). 
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Risk Factor Information for Brain and Central Nervous System Cancers 
 
Source: Community Assessment Program, Bureau of Environmental Health, Massachusetts Department of Public Health 
May 2006 
Brain and central nervous system (CNS) tumors can be either malignant (cancerous) or 
benign (non-cancerous).  Primary brain tumors (i.e., brain cancer) comprise two main 
types: gliomas and malignant meningiomas.  Gliomas are a general classification of 
malignant tumors that include a variety of types, named for the cells from which they 
arise: astrocytomas, oligodendrogliomas, and ependymomas.  Meningiomas arise from 
the meninges, which are tissues that surround the outer part of the spinal cord and brain.  
Although meningiomas are not technically brain tumors, as they occur outside of the 
brain, they account for about 25% of all reported primary brain tumors and the majority 
of spinal cord tumors.  The majority of meningiomas (about 85%) are benign and can be 
cured by surgery.  In addition to these main types, there are a number of rare brain 
tumors, including medulloblastomas, which develop from the neurons of the cerebellum 
and are most often seen in children.  Also, the brain is a site where both primary and 
secondary malignant tumors can arise; secondary brain tumors generally originate 
elsewhere in the body and then metastasize, or spread, to the brain (ACS 2006a).  The 
American Cancer Society estimates that 18,820 Americans (10,730 men and 8,090 
women) will be diagnosed with primary brain cancer (including cancers of the central 
nervous system, or spinal cord) and approximately 12,820 people (7,260 men and 5,560 
women) will die from this disease in 2006 (ACS 2006). 
Brain and spinal cord cancers account for over 20% of malignant tumors diagnosed 
among children aged 0-14 (ACS 2006b).  About half of all childhood brain tumors are 
astrocytomas and 25% are primitive neuroectodermal tumors (PNET), which spread 
along the spinal cord and the meninges (ACS 2006b).  After a peak in childhood 
(generally under 10 years of age), the risk of brain cancer increases with age from age 25 
to age 75.  In adults, the most frequent types of brain tumors are astrocytic tumors 
(mainly astrocytomas and glioblastoma multiforme).  Incidence rates are higher in males 
than in females for all types.  In general, the highest rates of brain and nervous system 
cancer tend to occur in whites.   However, this varies somewhat by type; the incidence of 
gliomas is lower among black men and women than whites, but for meningiomas, the 
reverse is true (Preston-Martin and Mack 1996). 
Despite numerous scientific and medical investigations, and analyses, the causes of brain 
cancer are still largely unknown.  Among the possible risk factors investigated in relation 
to this type of cancer are ionizing radiation, electromagnetic fields, occupational 
exposures, exposure to N-nitroso compounds, head trauma, and genetic disorders. 
The most established risk factor (and only established environmental risk factor) for brain 
tumors (either cancerous or non-cancerous) is high-dose exposure to ionizing radiation 
(i.e., x-rays and gamma rays).  Most radiation-induced brain tumors are caused by 
radiation to the head from the treatment of other cancers (ACS 2006a).  Meningiomas are 
the most common type of tumors that occur from this type of exposure, but gliomas may 
also occur (Preston-Martin and Mack 1996).  Among adults, the risk of developing 
meningiomas has been associated with full-mouth dental x-rays taken decades ago when 
radiation doses were higher than today.  Although the relationship between low-dose 
radiation exposure and increased risk of brain tumors has been debated in several studies, 
prenatal exposure from diagnostic x-rays has been related to an increase in childhood 
brain tumors (Preston-Martin and Mack 1996). 
Risk Factor Information for Brain and Central Nervous System Cancers 
 
Source: Community Assessment Program, Bureau of Environmental Health, Massachusetts Department of Public Health 
May 2006 
In recent years, there has been increasing public concern and scientific interest regarding 
the relationship of electromagnetic fields (EMF) to brain cancer.  However, results from 
recent epidemiological investigations provide little or no evidence of an association 
between residential EMF exposure (e.g., from power lines and home appliances) and 
brain tumors (Kheifets 2001).  Studies also suggest that the use of handheld cellular 
telephones is not associated with an increased risk of primary brain cancer (Muscat et al. 
2000).  However, given the relatively recent use of cellular phones, evidence is 
preliminary and few studies have been conducted. 
Other environmental factors such as exposure to vinyl chloride (used in the 
manufacturing of some plastics) and aspartame (a sugar substitute) have been suggested 
as possible risk factors for brain cancer but no conclusive evidence exists implicating 
these factors (ACS 2006a).  Although some occupational studies have suggested that 
electrical and electric utility workers may be at a slightly increased risk of brain cancer, 
these studies have important limitations, such as exposure misclassifications and a lack of 
dose-response relationships (Kheifets 2001).  Some researchers have also reported an 
increased risk of brain tumors in adults among veterinarians and farmers.  Exposures to 
farm animals and pets have been considered as possible risk factors because of their 
association with bacteria, pesticides, solvents, and certain animal oncogenic (cancer-
related) viruses (Yeni-Komshian and Holly 2000).  However, the relationship between 
farm life and brain cancer remains controversial. 
Recent reports have proposed a link between occupational exposure to lead and brain 
cancer risk, but further analytic studies are warranted to test this hypothesis (Cocco et al. 
1998).  In a case-control study, the concentrations of metal and non-metal compounds in 
brain biopsies from patients with primary brain tumors were compared to results from an 
analysis of tumor-free brain tissue.  Statistically significant associations were observed 
between the presence of brain tumors and the concentrations of silicon, magnesium, and 
calcium (Hadfield et al. 1998).  However, further research using a larger sample size is 
needed to determine whether exposure to these elements plays a role in the development 
of brain cancer.  Other occupations that may be associated with elevated risks include 
workers in certain health professions (e.g., pathologists and physicians), agricultural 
workers, workers in the nuclear industry, and workers in the rubber industry, although 
specific exposures have not been established (Preston-Martin and Mack 1996).  Studies 
investigating the possible association between occupational exposure of parents (in 
particular, paper or pulp-mill, aircraft, rubber, metal, construction, and electric workers) 
and the onset of brain tumors in their children have provided inconsistent results 
(Preston-Martin and Mack 1996). 
The association between the development of brain cancer and nitrites and other N-nitroso 
compounds, among the most potent of carcinogens, has been heavily researched.  N-
nitroso compounds have been found in tobacco smoke, cosmetics, automobile interiors, 
and cured meats.  A study concluded that an increased risk of pediatric brain tumor may 
be associated with high levels of nitrite intake from maternal cured meat consumption 
during pregnancy (Pogoda and Preston-Martin 2001).  However, the role of nitrites and 
cured meats in the development of brain cancer remains controversial (Blot et al. 1999; 
Bunin 2000).  Because most people have continuous, low level exposure to N-nitroso 
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May 2006 
compounds throughout their lives, further studies, especially cohort studies, are needed to 
determine if this exposure leads to an increased risk of brain tumors (Preston-Martin 
1996). 
Injury to the head has been suggested as a possible risk factor for later development of 
brain tumors but most researchers agree that there is no conclusive evidence for an 
association (ACS 2006a).  Head trauma is most strongly associated with the development 
of meningiomas compared with other types of brain tumor.  Several studies have found 
an increased risk in women with histories of head trauma; in men who boxed; and in men 
with a previous history of head injuries.  Gliomas are the most common type of childhood 
brain tumor and have been positively associated with trauma at birth (e.g., Cesarean 
section, prolonged labor, and forceps delivery).  However, other studies have found no 
association (Preston-Martin and Mack 1996). 
In addition, rare cases of brain and spinal cord cancer run in some families.  Brain tumors 
in some persons are associated with genetic disorders such as neurofibromatosis types I 
and II, Li-Fraumeni syndrome, and tuberous sclerosis.  Neurofibromatosis type I (von 
Recklinghausen’s disease) is the most common inherited cause of brain or spinal cord 
tumors and occurs in about one out of every 3,000 people (Preston-Martin and Mack 
1996).  The disease may be associated with optic gliomas or other gliomas of the brain or 
spinal cord (ACS 2006b).  Of those afflicted with the disease, about 5-10% will develop a 
central nervous system tumor (Preston-Martin and Mack 1996).  In addition, von Hippell-
Lindau disease is associated with an inherited tendency to develop blood vessel tumors of 
the cerebellum (ACS 2006b).  However, malignant (or cancerous) brain tumors are rare 
in these disorders; inherited syndromes that predispose individuals to brain tumors appear 
to be present in fewer than 5% of brain tumor patients (Preston-Martin and Mack 1996). 
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Risk Factor Information for Breast Cancer 
 
Source: Community Assessment Program, Bureau of Environmental Health, Massachusetts Department of Public Health 
May 2006 
Breast cancer is the most frequently diagnosed cancer among women in both the United 
States and in Massachusetts.  According to the American Cancer Society, female breast 
cancer incidence in Massachusetts is the fourth highest among all states (ACS 2006).  
The breast cancer incidence rate has been rising in the United States since the 1980s.  
However, the rate of increase slowed in the 1990s compared to the 1980s.  Most recently, 
breast cancer incidence has only increased in women over 50 years of age (ACS 2006a).  
A similar trend occurred in Massachusetts and there was even a significant decrease in 
incidence (2.5%) between 1998 and 2002 (MCR 2005). 
In the year 2006, approximately 212,920 women in the U.S. will be diagnosed with breast 
cancer (ACS 2006).  Worldwide, female breast cancer incidence has increased, mainly 
among women in older age groups whose proportion of the population continues to 
increase as well (van Dijck et al. 1997).  A woman’s risk for developing breast cancer can 
change over time due to many factors, some of which are dependent upon the well-
established risk factors for breast cancer.  These include increased age, an early age at 
menarche (menstruation) and/or late age at menopause, late age at first full-term 
pregnancy, family history of breast cancer, and high levels of estrogen.  Other risk factors 
that may contribute to a woman’s risk include benign breast disease and lifestyle factors 
such as diet, body weight, lack of physical activity, consumption of alcohol, and exposure 
to cigarette smoke.  Data on whether one’s risk may be affected by exposure to 
environmental chemicals or radiation remains inconclusive.  However, studies are 
continuing to investigate these factors and their relationship to breast cancer.   
Family history of breast cancer does affect one’s risk for developing the disease.  
Epidemiological studies have found that females who have a first-degree relative with 
premenopausal breast cancer experience a three-fold greater risk.  However, no increase 
in risk has been found for females with a first degree relative with postmenopausal breast 
cancer.  If women have a first-degree relative with bilateral breast cancer (cancer in both 
breasts) at any age, then their risk increases five-fold.  Moreover, if a woman has a 
mother, sister or daughter with bilateral premenopausal breast cancer, their risk increases 
nine-fold (Broeders and Verbeek 1997).  In addition, twins have a higher risk of breast 
cancer compared to non-twins (Weiss et al. 1997).  
A personal history of benign breast disease is also associated with development of 
invasive breast cancer.  Chronic cystic or fibrocystic disease is the most commonly 
diagnosed benign breast disease.  Women with cystic breast disease experience a 2-3 fold 
increase in risk for breast cancer (Henderson et al. 1996).  
According to recent studies, approximately 5 to 10% of breast cancers can be attributed 
to inherited mutations in breast cancer-related genes.  Most of these mutations occur in 
the BRCA1 and BRCA2 genes.  Women who inherit BRCA1 or BRCA2 gene mutations 
have up to an 80% chance of developing breast cancer at some point in their lifetimes 
(ACS 2006). 
Cumulative exposure of the breast tissue to estrogen and progesterone hormones may be 
one of the greatest contributors to risk for breast cancer (Henderson et al. 1996).  
Researchers suspect that early exposures to a high level of estrogen, even during fetal 
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development, may add to one’s risk of developing breast cancer later in life.  Other 
studies have found that factors associated with increased levels of estrogen (i.e., neonatal 
jaundice, severe prematurity, and being a fraternal twin) may contribute to an elevated 
risk of developing breast cancer (Ekbom et al. 1997).  Conversely, studies have revealed 
that women whose mothers experienced toxemia during pregnancy (a condition 
associated with low levels of estrogen) had a significantly reduced risk of developing 
breast cancer.  Use of estrogen replacement therapy is another factor associated with 
increased hormone levels and it has been found to confer a modest (less than two-fold) 
elevation in risk when used for 10-15 years or longer (Kelsey 1993).  Similarly, more 
recent use of oral contraceptives or use for 12 years or longer seems to confer a modest 
increase in risk for bilateral breast cancer in premenopausal women (Ursin et al. 1998). 
Cumulative lifetime exposure to estrogen may also be increased by certain reproductive 
events during one’s life. Women who experience menarche at an early age (before age 
12) have a 20% increase in risk compared to women who experience menarche at 14 
years of age or older (Broeders and Verbeek 1997; Harris et al. 1992; ACS 2006).  
Women who experience menopause at a later age (after the age of 55) have a slightly 
elevated risk for developing the disease (ACS 2006). Furthermore, the increased 
cumulative exposure from the combined effect of early menarche and late menopause has 
been associated with elevated risk (Lipworth 1995).  In fact, women who have been 
actively menstruating for 40 or more years are thought to have twice the risk of 
developing breast cancer than women with 30 years or less of menstrual activity 
(Henderson et al. 1996).  Other reproductive events have also shown a linear association 
with risk for breast cancer (Wohlfahrt 2001).  Specifically, women who gave birth for the 
first time before age 18 experience one-third the risk of women who have carried their 
first full-term pregnancy after age 30 (Boyle and Leake 1988).  The protective effect of 
earlier first full-term pregnancy appears to result from the reduced effect of circulating 
hormones on breast tissue after pregnancy (Kelsey 1993).  
Diet, and particularly fat intake, is another factor suggested to increase a woman’s risk 
for breast cancer.  Currently, a hypothesis exists that the type of fat in a woman's diet 
may be more important than her total fat intake (ACS 2006; Wynder et al. 1997).  
Monounsaturated fats (olive oil and canola oil) are associated with lower risk while 
polyunsaturated (corn oil, tub margarine) and saturated fats (from animal sources) are 
linked to an elevated risk.  However, when factoring in a woman’s weight with her 
dietary intake, the effect on risk becomes less clear (ACS 1998).  Many studies indicate 
that a heavy body weight elevates the risk for breast cancer in postmenopausal women 
(Kelsey 1993), probably due to fat tissue as the principal source of estrogen after 
menopause (McTiernan 1997).  Therefore, regular physical activity and a reduced body 
weight may decrease one’s exposure to the hormones believed to play an important role 
in increasing breast cancer risk (Thune et al. 1997).  
Aside from diet, regular alcohol consumption has also been associated with increased risk 
for breast cancer (Swanson et al. 1997; ACS 2006).  Women who consumed one 
alcoholic beverage per day experienced a slight increase in risk (approximately 10%) 
compared to non-drinkers, however those who consumed 2 to 5 drinks per day 
experienced a 1.5 times increased risk (Ellison et al. 2001; ACS 2006).  Despite this 
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association, the effects of alcohol on estrogen metabolism have not been fully 
investigated (Swanson et al. 1997).  
To date, no specific environmental factor, other than ionizing radiation, has been 
identified as a cause of breast cancer.  The role of cigarette smoking in the development 
of breast cancer is unclear.  Some studies suggest a relationship between passive smoking 
and increased risk for breast cancer; however, confirming this relationship has been 
difficult due to the lack of consistent results from studies investigating first-hand smoke 
exposure (Laden and Hunter 1998). 
Studies on exposure to high doses of ionizing radiation demonstrate a strong association 
with breast cancer risk.  These studies have been conducted in atomic bomb survivors 
from Japan as well as patients that have been subjected to radiotherapy in treatments for 
other conditions (i.e., Hodgkin lymphoma and non-Hodgkin’s Lymphoma) (ACS 2006).  
However, it has not been shown that radiation exposures experienced by the general 
public or people living in areas of high radiation levels from industrial accidents or 
nuclear activities are related to an increase in breast cancer risk (Laden and Hunter 1998). 
Investigations of electromagnetic field exposures in relation to breast cancer have been 
inconclusive as well. 
Occupational exposures associated with increased risk for breast cancer have not been 
clearly identified.  Experimental data suggest that exposure to certain organic solvents 
and other chemicals (e.g., benzene, trichloropropane, vinyl chloride, polycyclic aromatic 
hydrocarbons (PAHs)) causes the formation of breast tumors in animals and thus may 
contribute to such tumors in humans (Goldberg and Labreche 1996).  In particular, a 
significantly elevated risk for breast cancer was found for young women employed in 
solvent-using industries (Hansen 1999). Although risk for premenopausal breast cancer 
may be elevated in studies on occupational exposures to a combination of chemicals, 
including benzene and PAHs, other studies on cigarette smoke (a source of both 
chemicals) and breast cancer have not shown an associated risk (Petralia et al. 1999).  
Hence, although study findings have yielded conflicting results, evidence does exist to 
warrant further investigation into the associations. 
Other occupational and environmental exposures have been suggested to confer an 
increased risk for breast cancer in women, such as exposure to polychlorinated biphenyls 
(PCBs), chlorinated hydrocarbon pesticides (DDT and DDE), and other endocrine-
disrupting chemicals.  Because these compounds affect the body’s estrogen production 
and metabolism, they can contribute to the development and growth of breast tumors 
(Davis et al. 1997; Holford et al. 2000; Laden and Hunter 1998). However, studies on this 
association have yielded inconsistent results and follow-up studies are ongoing to further 
investigate any causal relationship (Safe 2000). 
When considering a possible relationship between any exposure and the development of 
cancer, it is important to consider the latency period.  Latency refers to the time between 
exposure to a causative factor and the development of the disease outcome, in this case 
breast cancer.  It has been reported that there is an 8 to 15 year latency period for breast 
cancer (Petralia et al. 1999; Aschengrau et al. 1998; Lewis-Michl et al. 1996).  This 
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means that if an environmental exposure were related to breast cancer, it may take 8 to 15 
years after exposure to a causative factor for breast cancer to develop.  
Socioeconomic differences in breast cancer incidence may be a result of current 
screening participation rates.  Currently, women of higher socioeconomic status (SES) 
have higher screening rates, which may result in more of the cases being detected in these 
women.  However, women of higher SES may also have an increased risk for developing 
the disease due to different reproductive patterns (i.e., parity, age at first full-term birth, 
and age at menarche).  Although women of lower SES show lower incidence rates of 
breast cancer, their cancers tend to be diagnosed at a later stage (Segnan 1997).  Hence, 
rates for their cancers may appear lower due to the lack of screening participation rather 
than a decreased risk for the disease.  Moreover, it is likely that SES is not in itself the 
associated risk factor for breast cancer.  Rather, SES probably represents different 
patterns of reproductive choices, occupational backgrounds, environmental exposures, 
and lifestyle factors (i.e., diet, physical activity, cultural practices) (Henderson et al. 
1996). 
Despite the vast number of studies on the causation of breast cancer, known factors are 
estimated to account for less than half of breast cancers in the general population 
(Madigan et al. 1995).  Researchers are continuing to examine potential risks for 
developing breast cancer, especially environmental factors.   
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Hodgkin lymphoma is a form of cancer that occurs in the lymphatic system, which 
accounts for a major part of our immune defense.  Hodgkin lymphoma occurs specifically 
in the Reed-Sternberg cells, a type of B lymphocyte, or white blood cell; while other 
lymphomas (non-Hodgkin types) occur in different cells.  The most common type of the 
disease is nodular sclerosis Hodgkin’s, which accounts for about 70-80% of diagnoses in 
developed countries; other types include mixed cellularity Hodgkin’s, lymphocyte-rich 
Hodgkin’s, and lymphocyte-poor Hodgkin’s.  These four types of the disease make up 
what is known as classical Hodgkin lymphoma, and collectively represent 95% of all 
diagnoses of the disease.  The other 5% of diagnoses fall into the category of nodular 
lymphocyte predominance Hodgkin lymphoma (ACS 2007).  The American Cancer 
Society estimates that there will be approximately 8,190 new cases of Hodgkin 
lymphoma in the U.S. in 2007, accounting for less than 1% of all cancer types, and 
approximately 1,070 deaths (ACS 2007).  Because of substantial improvement in 
effective therapy for this disease, mortality rates have decreased approximately 60% 
since the early 1970s (ACS 2007). 
Epidemiologic studies have shown that Hodgkin lymphoma is more common among men 
than women and more common among white people than African-Americans.  People of 
Jewish descent appear to be at higher risk of Hodgkin lymphoma compared to people of 
non-Jewish descent (Mueller 1996).  Although the disease is relatively rare among 
children, two peaks in the bimodal age distribution have been observed for this cancer 
type.  The first peak occurs in young adults usually between the ages of 15 to 40 
(typically ages 25-30) and the second peak occurs in adults aged 55 years and above 
(ACS 2007).   
Slightly higher rates of Hodgkin lymphoma occur among people with reduced immunity, 
such as those with AIDS, people with congenital immune deficiencies, and individuals on 
immunosuppressant medication following organ transplants.  However, Hodgkin 
lymphoma occurs at a much lower rate than non-Hodgkin lymphomas among this group 
of individuals (ACS 2007). 
Scientists have identified few risk factors that may make a person more likely to develop 
Hodgkin lymphoma.  The bimodal age distribution of this disease suggests that two 
distinct etiologies (or causes) for Hodgkin lymphoma may be involved for each group.  
Hodgkin lymphoma trends in the young adult population reveal that the disease has 
become increasingly associated with populations both of middle to higher socioeconomic 
status and small family size.  These factors are consistent with susceptibility to late 
infections with common childhood viruses, supporting the theory that Hodgkin 
lymphoma is associated with an infectious agent (Mueller 1996).   
A four times higher rate of Hodgkin lymphoma has been observed in individuals who 
have had infectious mononucleosis, an infection that is caused by the Epstein-Barr virus 
(EBV).  The virus is present in the lymph nodes of approximately half of the individuals 
diagnosed with Hodgkin lymphoma the other half have no evidence of EBV in their 
Hodgkin cells (ACS 2007).    The absence of EBV infection in about half the cases and 
the high prevalence of EBV in the general population suggest that EBV may be only one 
of several factors in the development of this cancer.  Although cytomegalovirus (CMV) 
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and the more recently identified human herpesvirus type 6 have been considered as 
possible factors in the development of Hodgkin lymphoma, results of antibody studies are 
inconsistent and these viruses do not appear to be related to the risk of Hodgkin 
lymphoma (Mueller 1996). 
Occupational exposures to workers in the chemical industry and woodworkers have also 
been suggested in several epidemiologic studies to be associated with the development of 
Hodgkin lymphoma.  However, specific chemical exposures related to the development 
of this disease have not been identified and results of studies investigating occupational 
exposures are inconsistent (Mueller 1996).  Based on an examination of medical and 
scientific literature, the American Cancer Society concludes that although the exact cause 
remains unknown, Hodgkin lymphoma does not seem to be caused by lifestyle (e.g., diet, 
smoking status), or environmental factors (ACS 2007). 
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Kidney cancer involves a number of tumor types located in various areas of the kidney 
and renal system.  Renal cell cancer (which affects the main area of the kidney) accounts 
for over 90% of all malignant kidney tumors (ACS 2006).  The American Cancer Society 
estimates that there will be approximately 38,890 cases of kidney and upper urinary tract 
cancer, resulting in more than 12,840 deaths in 2006 (ACS 2006).  Kidney cancer is twice 
as common in males as it is in females and the incidence most often occurs in individuals 
between 55 and 84 years of age (ACS 2006).  The gender distribution of this disease may 
be attributed to the fact that men are more likely to smoke and are more likely to be 
exposed to potentially carcinogenic chemicals at work. 
Since 1970, U.S. incidence rates for renal cell cancer have risen between 2% and 4% 
annually among the four major race and gender groups (i.e., white males, white females, 
black males, and black females) (Chow et al. 1999; McLaughlin et al. 1996).  Rapid 
increases in incidence among blacks as compared to among whites have resulted in an 
excess of the disease among blacks; age-adjusted incidence rates between 1975 and 1995 for 
white men, white women, black men, and black women were 9.6, 4.4, 11.1, and 4.9 per 
100,000 person-years, respectively (Chow et al. 1999).  Rising incidence rates may be 
partially due to the increased availability of screening for kidney cancer. 
The etiology of kidney cancer is not fully understood.  However, a number of 
environmental, cellular, and genetic factors have been studied as possible causal factors in 
the development of renal cell carcinoma.  Cigarette smoking is the most important known 
risk factor for renal cell cancer.  Smoking increases the risk of developing renal cell cancer 
by about 40% (ACS 2006).  In both males and females, a statistically significant dose-
response relationship between smoking and this cancer has been observed (Yuan et al. 
1998).  
Virtually every study that has examined body weight and renal cell cancer has observed a 
positive association.  Some studies suggest that obesity is a factor in 20% of people who 
develop kidney cancer (ACS 2006).  A diet high in protein (meat, animal fats, milk 
products, margarine and oils) has been implicated in epidemiological studies as a risk factor 
for renal cell carcinoma (McLaughlin et al. 1996).  Consumption of adequate amounts of 
fruits and vegetables lowers the risk of renal cell cancer.  In addition, use of diuretics and 
antihypertensive medications are associated with increased risk of renal cell carcinoma.  
However, hypertension has also been linked to kidney cancer and it is not clear whether the 
disease or the medications used to treat them is the cause (ACS 2000).  Long-term use of 
pain relievers such as phenacetin (and possibly acetaminophen and aspirin) increases the 
risk for cancer of the renal pelvis and renal cell carcinoma (McLaughlin et al. 1996). 
Certain medical conditions that affect the kidneys have also been shown to increase 
kidney cancer risk.  There is an increased incidence of renal carcinoma in patients with 
end-stage renal disease who develop acquired cystic disease of the kidney.  This 
phenomenon is seen among patients on long-term dialysis for renal failure (Linehan et al. 
1997).  In addition, an association has been established between the incidence of von 
Hippel-Lindau disease and certain other inherited conditions in families and renal cell 
carcinoma, suggesting that genetic and hereditary risk factors may be important in the 
development of kidney cancer (ACS 2006; McLaughlin et al. 1996). 
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Environmental and occupational factors have also been associated with the development of 
kidney cancer.  Some studies have shown an increased incidence of this cancer type among 
leather tanners, shoe workers, and workers exposed to asbestos.  Exposure to cadmium is 
associated with an increased incidence of kidney cancer, particularly in men who smoke 
(ACS 2006; Linehan et al. 1997).   In addition, workplace exposure to organic solvents, 
particularly trichloroethylene, may increase the risk of this cancer (ACS 2006).  Although 
occupational exposure to petroleum, tar, and pitch products has been implicated in the 
development of kidney cancer, most studies of oil refinery workers and petroleum products 
distribution workers have not identified a definitive relationship between gasoline exposure 
and renal cancer (Linehan et al. 1997; McLaughlin et al. 1996). 
Wilms’ tumor is the most common type of kidney cancer affecting children and accounts for 
approximately 5% to 6% of all kidney cancers and about 6% of all childhood cancers.  This 
cancer is more common among African Americans than other races and among females than 
males.  Wilms’ tumor most often occurs in children under the age of 7 years.  The causes of 
Wilms’ tumor are not known, but certain birth defect syndromes and other genetic risk 
factors (such as family history or genetic mutations) are connected with this cancer.  
However, most children who develop Wilms’ tumor do not have any known birth defects or 
inherited gene changes.  No environmental risk factors, either before or after a child’s birth, 
have been shown to be associated with the development of Wilms’ tumor (ACS 2006a). 
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Leukemia is the general term that includes a group of different cancers that occur in the 
blood forming organs and result in the formation of abnormal amounts and types of white 
blood cells in the blood and bone marrow.  Individuals with leukemia generally maintain 
abnormally high amounts of leukocytes or white blood cells in their blood.  This 
condition results in an individual’s inability to maintain certain body functions, 
particularly a person’s ability to combat infection. 
In 2006, leukemia is expected to affect approximately 35,070 individuals in the United 
States (20,000 males and 15,070 females) in the United States, resulting in 22,280 deaths. 
Acute cases of leukemia are slightly more common that chronic, 15,860 and 14,520 
respectively. In Massachusetts, approximately 770 individuals will be diagnosed with the 
disease in 2006, representing more than 2% of all cancer diagnoses. There are four major 
types of leukemia: acute lymphoid leukemia (ALL), acute myeloid leukemia (AML), 
chronic lymphoid leukemia (CLL), and chronic myeloid leukemia (CML).  There are also 
a few rare types, such as hairy cell leukemia.  In adults, the most common types are AML 
(approximately 11,700 cases) and CLL (approximately 9,560 cases). Incidences of ALL 
have increased approximately 1.8% per year since 1988 while incidences of CLL have 
decreased approximately 1.9% each year since 1988. Leukemia is the most common type 
of childhood cancer, accounting for about 30% of all cancers diagnosed in children.  The 
majority (74%) of these cases are of the ALL type (ACS 2006a). 
While ALL occurs predominantly among children (peaking between ages 2 and 3 years), 
an elevation in incidence is also seen among older individuals, and 1300 (one-third) of 
total cases of ALL will occur in adults. ALL risk is lowest for adults aged 25 through 50 
and then begins to pick up (ACS 2006b). The increase in incidence among older 
individuals begins at approximately 40-50 years of age, peaking at about age 85 (Linet 
and Cartwright 1996).  ALL is more common among whites than African Americans and 
among males than females (Weinstein and Tarbell 1997).  Exposure to high-dose 
radiation (e.g., by survivors of atomic bomb blasts or nuclear reactor accidents) is a 
known environmental risk factor associated with the development of ALL (ACS 2006b).  
Significant radiation exposure (e.g., diagnostic x-rays) within the first few months of 
development may carry up to a 5-fold increased risk of developing ALL (ACS 2006b).  
However, few studies report an increased risk of leukemia associated with residing in 
proximity to nuclear plants or occupational exposure to low-dose radiation (Linet and 
Cartwright 1996; Scheinberg et al. 1997).  There is conflicting evidence about whether 
exposure to electromagnetic fields (EMF) plays a role in the development of ALL, 
however, most studies to date have found little or no risk (ACS 2006b). 
Few other risk factors for ALL have been identified.  There is evidence that genetics may 
play an important role in the development of this leukemia type.  Studies indicate that 
siblings of twins who develop leukemia are at an increased risk of developing the disease.  
Children with Down’s syndrome are 10 to 20 times more likely to develop acute 
leukemia (Weinstein and Tarbell 1997).  In addition, other genetic diseases, such as Li-
Fraumeni syndrome and Klinefelter’s syndrome, are associated with an increased risk of 
developing leukemia.  Patients receiving medication that suppresses the immune system 
(e.g., organ transplant patients) may be more likely to develop ALL (ACS 2006c).  ALL 
has not been definitively linked to chemical exposure, however, childhood ALL may be 
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associated with maternal occupational exposure to pesticides during pregnancy (Infante-
Rivard et al. 1999).  Certain rare types of adult ALL are caused by human T-cell 
leukemia/lymphoma virus-I (HTLV-I) (ACS 2006c).  Some reports have linked other 
viruses with various types of leukemia, including Epstein-Barr virus and hepatitis B 
virus.  Still others propose that leukemia may develop as a response to viral infection.  
However, no specific virus has been identified as related to ALL (Linet and Cartwright 
1996).  Reports also suggest an infectious etiology for some childhood ALL cases, 
although a specific viral agent has not been identified and findings from studies exploring 
contact among children in day-care do not support this hypothesis (Greaves MF 1997; 
Kinlen and Balkwill 2001; Rosenbaum et al. 2000). 
Although AML can occur in children (usually during the first two years of life), AML is 
the most common leukemia among adults, with an average age at diagnosis of 65 years 
(ACS 2006d).  This type of leukemia is more common among males than among females 
but affects African Americans and whites at similar rates (Scheinberg et al. 1997).  High-
dose radiation exposure (e.g., by survivors of atomic bomb blasts or nuclear reactor 
accidents), long-term occupational exposure to benzene (a chemical in gasoline and 
cigarette smoke), and exposure to certain chemotherapy drugs, especially alkylating 
agents (e.g., mechlorethamine, cyclophosphamide), have been associated with an 
increased risk of developing AML among both children and adults (ACS 2006d).  The 
development of childhood AML is suspected to be related to parental exposure to 
pesticides and other chemicals, although findings are inconsistent (Linet and Cartwright 
1996).  Studies have suggested a link between electromagnetic field (EMF) exposure 
(e.g., from power lines) and leukemia (Minder and Pfluger 2001; Schuz et al. 2001).  
However, there is conflicting evidence regarding EMF exposure and leukemia and it is 
clear that most cases are not related to EMF (Kleinerman et al. 2000). 
Other possible risk factors related to the development of AML include cigarette smoking 
and genetic disorders.  It is estimated that approximately one-fifth of cases of AML are 
caused by smoking (Scheinberg et al. 1997).  Also, a small number of AML cases can be 
attributed to rare inherited disorders, such as Down’s syndrome (ACS 2006d).  Recently, 
scientists have suggested that a mutation in a gene responsible for the deactivation of 
certain toxic metabolites may have the ability to increase the risk of acute myeloid 
leukemia in adults.  However, further research is necessary in order to confirm the 
findings of this study (Smith et al. 2001).  
CLL is chiefly an adult disease; the average age at diagnosis is about 70 years (ACS 
2006e). Twice as many men as women are affected by this type of leukemia (Deisseroth 
et al. 1997).  While genetics and diseases of the immune system have been suggested as 
playing a role in the development of CLL, high-dose radiation and benzene exposure 
have not (ACS 1999; Weinstein and Tarbell 1997).  It is thought that individuals with a 
family history of CLL are two to four times as likely to develop the disease.  Some 
studies have identified an increased risk of developing CLL (as well as ALL, AML, and 
CML) among farmers due to long-term exposure to herbicides and/or pesticides (Linet 
and Cartwright 1996).  Although viruses have been implicated in the etiology of other 
leukemias, there is no evidence that viruses cause CLL (Deisseroth et al. 1997). 
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Of all the leukemias, CML is among the least understood.  While this disease can occur at 
any age, CML is extremely rare in children (about 2% of leukemias in children) and the 
average age of diagnosis is 40 to 50 years (ACS 2006f).  Incidence rates are higher in 
males than in females, but unlike the other leukemia types, rates are higher in blacks than 
in whites in the U.S. (Linet and Cartwright 1996).  High-dose radiation exposure may 
increase the risk of developing CML (ACS 2006f).  Finally, CML has been associated 
with chromosome abnormalities such as the Philadelphia chromosome (Weinstein and 
Tarbell 1997). 
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An estimated 18,510 people in the U.S. (12,600 men and 5,910 women) will be 
diagnosed with liver and intrahepatic bile duct cancer in 2006, accounting for 
approximately 1% of all new cancers (ACS 2006).  Hepatocellular carcinoma (HCC) is 
the most common primary cancer of the liver and accounts for about 75% of all cases.  
Rarer forms of malignant liver cancer include the fibrolamellar subtype of HCC, 
cholangiocarcinoma, and angiosarcomain adults and hepatoblastoma in children.  
Cholangriocarcinomas account for approximately 10% to 20% of all primary liver 
cancers and people with gallstones, gall bladder inflammation, chronic ulcerative colitis 
(long-standing inflammation of the large bowel) or chronic infection with certain types of 
parasitic worms are at an increased risk for developing this cancer.  Hepatoblastoma is a 
rare cancer that forms usually in children under age 4 and has a 90% survival rate with 
early detection (ACS 2006a). 
In some developing countries, HCC is most common type of cancer diagnosed 
particularly in East Asia and Africa.   Incidence in the United States had been increasing 
up to 1999.  Recently, the rate has become more stable (ACS 2006a).  Rates of HCC in 
the U.S. had increased by 70% during the 1980s and 1990s (Yu et al. 2000).  Similar 
trends were observed in Canada and Western Europe.  The primary reason for the higher 
rates observed during those years was the increase in hepatitis C virus infection, an 
important factor related to liver cancer (El-Serag 2001; El-Serag and Mason 2000).   
Men are at least three times more likely to develop HCC than women.  Much of this is 
likely due to differences in lifestyle factors which increase a person’s risk for developing 
liver cancer (ACS 2006a).  Although 85% of individuals diagnosed with liver cancer are 
between 45 and 85 years of age, the disease can occur in persons of any age (ACS 
2006a). 
Several important risk factors for liver cancer have been identified.  Chronic infection 
with hepatitis B virus (HBV) and hepatitis C virus (HCV) are the most significant risk 
factors for developing liver cancer (ACS 2006a).  It is estimated that 80% of HCC cases 
worldwide can be attributed to HBV infection (Yu et al. 2000).  In the United States, 
HBV accounts for less than a quarter of the cases and infection with HCV plays a much 
larger role in the incidence of this cancer.  HBV and HCV can be spread through 
intravenous drug use (e.g., the sharing of contaminated needles), unprotected sexual 
intercourse, and transfusion of and contact with unscreened blood and blood products.  In 
addition, mothers who are infected with these viruses can pass them on to their children 
at birth or in early infancy (ACS 2006a). 
Cirrhosis is also a major risk factor for the development of liver cancer.  Cirrhosis is a 
progressive disease that is the result of scar tissue formation on the liver, which can lead 
to cancer.  Researchers estimate that 60% to 80% of HCC cases are associated with 
cirrhosis.  However, it is unclear if cirrhosis itself causes liver cancer or if the underlying 
causes of cirrhosis contribute to the development of this disease (Garr et al. 1997).  Most 
liver cirrhosis in the U.S. occurs as a result of chronic alcohol abuse, but HBV and HCV 
are also major causes of cirrhosis (ACS 2006a).  In addition, certain inherited metabolic 
diseases, such as hemochromatosis, which causes excess iron accumulation in the body, 
can lead to cirrhosis (ACS 2006a).  Some studies have shown that people with 
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hemochromatosis are at an increased risk of developing liver cancer (Fracanzani et al. 
2001). 
Epidemiological and environmental evidence indicates that exposure to certain chemicals 
and toxins can also contribute significantly to the development of liver cancer.  For 
example, chronic consumption of alcoholic beverages has been associated with liver 
cancer (Wogan 2000).  As noted above, it is unclear if alcohol itself causes HCC or if 
underlying cirrhosis is the cause (London and McGlynn 1996).  However, it is clear that 
alcohol abuse can accelerate liver disease and may act as a co-carcinogen in the 
development of liver cancer (Ince and Wands 1999).  Long-term exposure to aflatoxin 
can also cause liver cancer.  Aflatoxins are carcinogenic agents produced by a fungus 
found in tropical and subtropical regions.  Individuals may be exposed to aflatoxins if 
they consume contaminated peanuts and other foods that have been stored under hot, 
humid conditions (Wogan 2000).  Vinyl chloride, a known human carcinogen used in the 
manufacturing of some plastics, and thorium dioxide, used in the past for certain x-ray 
tests, are risk factors for a rare type of liver cancer called angiosarcoma (ACS 2006a; 
London and McGlynn 1996).  These chemicals may also increase the risk of 
cholangiocarcinoma and HCC, but to a lesser degree.  The impact of both thorium 
dioxide and vinyl chloride on the incidence of liver cancer was much greater in the past, 
since thorium dioxide has not been used for decades and exposure of workers to vinyl 
chloride is now strictly regulated in the U.S. (ACS 2006a).  Drinking water contaminated 
with arsenic may increase the risk of liver cancer in some parts of the world (ACS 2006a; 
ATSDR 2001). 
The use of oral contraceptives by women may also be a risk factor in the development of 
liver cancer.  However, most of the studies linking oral contraceptives and HCC involved 
types of oral contraceptives that are no longer used.  There is some indication that the 
increased risk may be confined to oral contraceptives containing mestranol.  It is not 
known if the newer oral contraceptives, which contain different types and doses of 
estrogen and different combinations of estrogen with other hormones, significantly 
increase the risk of HCC (ACS 2006a; London and McGlynn 1996).  Long-term anabolic 
steroid use may slightly increase the risk of HCC (ACS 2006a).  Although many 
researchers believe that cigarette smoking plays a role in the development of liver cancer, 
the evidence for this is still inconclusive (Mizoue et al. 2000; London and McGlynn 
1996). 
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Lung cancer generally arises in the epithelial tissue of the lung.  Several different 
histologic or cell types of lung cancer have been observed.  The various types of lung 
cancer occur in different regions of the lung and each type is associated with slightly 
different risk factors (Blot and Fraumeni 1996).  The most common type of lung cancer 
in the United States today is adenocarcinoma which accounts for about 40% of all lung 
cancers (ACS 2005).  The greatest established risk factor for all types of lung cancer is 
cigarette smoking, followed by occupational and environmental exposures. 
The incidence of lung cancer increases sharply with age peaking at about age 60 or 70.  
Lung cancer is very rare in people under the age of 40.  The incidence is greater among 
men than women (probably because men are more likely to be smokers than women) and 
among blacks than whites (Blot and Fraumeni 1996).  The American Cancer Society 
estimates that lung and bronchus cancer will be diagnosed in 174,470 people (92,700 
cases in men and 81,770 in women) in the U.S. in 2006, accounting for about 12% of all 
new cancer diagnoses. For purposes of treatment, lung cancer is divided into two clinical 
groups: small cell lung cancer (13%) and non-small cell lung cancer (87%) (ACS 2006).  
Lung cancer is the leading cause of cancer death among both men and women; more 
people die of lung cancer than of colon, breast, and prostate cancers combined (ACS 
2005).  In Massachusetts, an estimated 4,070 individuals will be diagnosed with lung and 
bronchus cancer in 2006.  Incidence rates for lung and bronchus cancer in Massachusetts 
from 1998 through 2002 were 86.5 per 100,000 and 60.4 per 100,000 for males and 
females, respectively (ACS 2006).  Nationwide, the incidence rate declined significantly 
in men during the 1990s, most likely as a result of decreased smoking rates over the past 
30 years.  Rates for women are approaching a plateau, after a long period of increase. 
This is likely because decreasing smoking patterns among women have lagged behind 
those of men (ACS 2006).  Trends in lung cancer incidence suggest that the disease has 
become increasingly associated with populations of lower socioeconomic status, since 
these individuals have higher rates of smoking than individuals of other groups (Blot and 
Fraumeni 1996). 
Approximately 87% of all lung cancers are caused directly by smoking cigarettes and 
some of the rest are due to exposure to second hand smoke, or environmental tobacco 
smoke.  The longer a person has been smoking and the higher the number of cigarettes 
smoked per day, the greater the risk of lung cancer.  Smoking cessation decreases the 
elevated risk and ten years after smoking cessation the risk is reduced by one-third of 
what it would have been had smoking continued. However, former smokers still carry a 
greater risk than those who have never smoked.  There is no evidence that smoking low 
tar or “light” cigarettes reduces the risk of lung cancer and mentholated cigarettes are 
thought to increase the risk of lung cancer.  Additionally, breathing secondhand smoke 
also increases an individual’s risk of developing lung cancer. A nonsmoking spouse of a 
smoker has a 30% greater risk of developing lung cancer than the spouse of a nonsmoker 
(ACS 2005). 
Workplace exposures have also been identified as playing important roles in the 
development of lung cancer.  Occupational exposure to asbestos is an established risk 
factor for this disease; asbestos workers are about seven times more likely to die from 
lung cancer than the general population (ACS 2005).  Underground miners exposed to 
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radon and uranium are at an increased risk for developing lung cancer (Samet and Eradze 
2000).  Chemical workers, talc miners and millers, paper and pulp workers, carpenters, 
metal workers, butchers and meat packers, vineyard workers, carpenters and painters, and 
shipyard and railroad manufacture workers are some of the occupations associated with 
an increased risk of lung cancer (Blot and Fraumeni 1996; Pohlabeln et al. 2000).  In 
addition to asbestos and radon, chemical compounds such as arsenic, chloromethyl 
ethers, chromium, vinyl chloride, nickel chromates, coal products, mustard gas, ionizing 
radiation, and fuels such as gasoline are also occupational risk factors for lung cancer 
(ACS 2005; Blot and Fraumeni 1996).  Industrial sand workers exposed to crystalline 
silica are also at an increased risk for lung cancer (Rice et al. 2001; Steenland and 
Sanderson 2001).  Occupational exposure to the compounds noted above in conjunction 
with cigarette smoking dramatically increases the risk of developing lung cancer (Blot 
and Fraumeni 1996). 
As noted above, exposure to radon (a naturally occurring radioactive gas produced by the 
breakdown of radium and uranium) has been associated with increased risk of developing 
lung cancer among miners.  Recently, a number of studies have demonstrated that 
exposure to elevated levels of residential radon may also increase lung cancer risk (Lubin 
and Boice 1997; Kreienbrock et al. 2001; Tomasek et al. 2001).  Epidemiological 
evidence suggests that radon may be the second leading cause of lung cancer after 
smoking (Samet and Eradze 2000).  However, actual lung cancer risk is determined by 
cumulative lifetime exposure to indoor radon.  Therefore, normal patterns of residential 
mobility suggest that most people living in high-radon homes experience lifetime 
exposures equivalent to residing in homes with lower radon levels (Warner et al. 1996). 
Some types of pneumonia may increase the risk of lung cancer due to scarred lung tissue 
(ACS 2002).  In addition, people who have had lung cancer have a higher risk of 
developing another tumor.  A family history of lung cancer also increases an individual’s 
risk this is due to an abnormality on chromosome 6 (ACS 2005). 
Air pollution may increase the risk of developing lung cancer in some cities.  However, 
this risk is much lower than that due to cigarette smoking (ACS 2005). 
Diet has also been implicated in the etiology of lung cancer, however, the exact 
relationship is unclear.  Diets high in fruits and vegetables decrease lung cancer risk, but 
the reasons for this are unknown (Brownson et al. 1998).  A study showed a positive 
association between total fat, monounsaturated fat, and saturated fat and lung cancer 
among males, however, this effect was not observed among women (Bandera et al. 
1997). 
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Lymphomas are cancers involving the cells of the lymphatic system.  The majority of 
lymphomas involve the lymph nodes and spleen but the disease may also affect other 
areas within the body.  Non-Hodgkin lymphoma (NHL) is a classification of all 
lymphomas except Hodgkin lymphoma.  Thus NHL is a mixed group of diseases that is 
characterized by the malignant increase in specific cells of the immune system (B or T 
lymphocytes).  B-cell lymphomas are more common than T-cell lymphomas, accounting 
for about 85% of all cases of NHL (ACS 2006a).  The various types of NHL are thought 
to represent different diseases with different causes (Scherr and Mueller 1996).  NHL can 
occur at any age.  However, the average age at diagnosis is in the early 60s and the 
incidence of this disease generally increases with age.  This disease is more common in 
men than in women and affects whites more often than African Americans or Asian 
Americans (ACS 2006a).  The American Cancer Society estimates that approximately 
58,870 Americans will be diagnosed with NHL in 2006 with 30,680 diagnoses occurring 
among males and 28,190 diagnoses occurring among females (ACS 2006b). 
Overall, between 1973 and 1997, the incidence of NHL in the U.S. grew 81% (Garber 
2001), although over the past 20 years, the incidence rate appears to have stabilized (ACS 
2006b).  In Massachusetts, the incidence of NHL increased 50% during 1982-1997 from 
10.5 cases per 100,000 to 15.7 cases per 100,000 (MCR 1997, 2000).  The increase in 
NHL incidence has been attributed to better diagnosis, greater exposure to causative 
agents, and, to a lesser extent, the increasing incidence of AIDS-related lymphomas 
(Devesa and Fears 1992; Scherr and Mueller 1996).  Although the primary factors related 
to the development of NHL include conditions that suppress the immune system, viral 
infections, and certain occupational exposures, these factors are thought to account for 
only a portion of the increase observed in this cancer type (Scherr and Mueller 1996).   
NHL is more common among people who have abnormal or compromised immune 
systems, such as those with inherited diseases that suppress the immune system, individuals 
with autoimmune disorders, and people taking immunosuppressant drugs following organ 
transplants.  Genetic predisposition (e.g., inherited immune deficiencies) only accounts for a 
small proportion of NHL cases (Scherr and Mueller 1996).  AIDS patients have a 100- to 
300-fold higher risk for NHL than the general population (again, these cases account for 
only a minor part of overall NHL incidence) (Garber 2001).  NHL has also been reported to 
occur more frequently among individuals with conditions that require medical treatment 
resulting in suppression of the immune system, such as cancer chemotherapy.  However, 
current evidence suggests that the development of NHL is related to suppression of the 
individual’s immune system as a result of treatment, rather than the treatment itself (Scherr 
and Mueller 1996). 
Several viruses have been shown to play a role in the development of NHL.  Among organ 
transplant recipients, suppression of the immune system required for acceptance of the 
transplant leads to a loss of control or the reactivation of viruses that have been dormant in 
the body [e.g., Epstein - Barr virus (EBV) and herpes virus infections].  In addition, because 
cancer-causing viruses are known to cause lymphomas in various animals, it has been 
proposed that these types of viruses may also be associated with the development of NHL 
among humans without compromised immune systems.  Infection with the human T-cell 
leukemia/lymphoma virus (HTLV-I) is known to cause T-cell lymphoma among adults.  
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However, this is a relatively rare infection and most likely contributes only a small amount 
to the total incidence of NHL (Scherr and Mueller 1996).  EBV infection is common among 
the general population and has been shown to play a role in the development of most cases 
of transplant and AIDS related NHL.  Although viruses are causal factors for some subtypes 
of NHL, to date, studies have shown that the role of EBV in the development of NHL in the 
general population may not be large (Scherr and Mueller 1996).  Moreover, the high 
prevalence of EBV in the general population suggests that EBV may be only one of several 
factors in the development of this cancer. 
Recent studies have found that a type of bacteria, Helicobacter pylori, a common cause of 
stomach ulcers, can also cause some lymphomas of the stomach (ACS 2006).  An important 
implication of this finding is that treatment with antibiotics could prevent some NHL of the 
stomach. 
Some occupations have been associated with an increased risk of developing NHL, such as 
occupations related to chemicals or agriculture.  Farmers, herbicide and pesticide 
applicators, and grain workers appear to have the most increased risk (Zahm 1990, 1993; 
Tatham et al. 1997).  Studies conducted among agricultural workers have demonstrated 
increases in NHL among those using herbicides for more than 20 days per year and 
individuals who mix or apply herbicides.  A greater incidence of NHL appears to be related 
specifically to exposure to the herbicide 2,4-dichlorophenoxyacetic acid (2,4-D) and 
organophosphate insecticides (Wigle et al. 1990; Zahm et al. 1990; Zahm et al. 1993).  
Further studies of exposure to these chemicals and NHL incidence have shown that the 
increased risk is attributed to a specific impurity, 2,3,7,8-tetrachlorodibenzo-p-dioxin or 
2,3,7,8-TCDD, present in these herbicides.  However, reports of accidental industrial 
exposures to TCDD alone have not demonstrated an increased risk of NHL (Scherr and 
Mueller 1996).  An elevated risk for NHL development has also been noted among fence 
workers, orchard workers, and meat workers.  High-dose exposure to benzene has been 
associated with NHL (ACS 2006a).  However, a recent international cohort study indicated 
that petroleum workers exposed to benzene were not at an increased risk of NHL (Wong 
and Raabe 2000). 
In addition, epidemiological studies of long-term users of permanent hair coloring 
products have suggested an increased incidence of NHL (Zahm et al. 1992; Scherr and 
Mueller 1996).  However, a population based study found no association between the use 
of hair color products and an increased risk of developing NHL.  The researchers further 
stated that results from this study and previous studies, including experimental animal 
studies, provide little convincing evidence linking NHL with normal use of hair dye 
(Holly et al. 1998). 
Although radiation (e.g., nuclear explosions or radioactive fallout from reactor accidents) 
has been implicated in the development of some cancers, including NHL (ACS 2006a), 
there is little evidence for an increased risk of lymphoma due to radiation (Scherr and 
Mueller 1996). 
Studies have suggested that contamination of drinking water with nitrate may be associated 
with an increased risk of NHL (Ward et al. 1996).  Nitrate forms N-nitroso compounds 
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which are known carcinogens and can be found in smoked or salt-dried fish, bacon, 
sausages, other cured meats, beer, pickled vegetables, and mushrooms. 
Smoking has also been suggested to increase the risk of NHL.  A study that evaluated the 
history of tobacco use and deaths from NHL determined that people who had ever smoked 
had a two-fold increase of dying from NHL as compared to those who never smoked.  
Further, a four-fold increase was found among the heaviest smokers (Linet et al. 1992).  In 
addition, a more recent study that primarily examined occupation and NHL risk found a 
significant association with high levels of cigarette smoking and all NHL types (Tatham et 
al. 1997).  However, a review of five cohort studies and 14 case-control studies concludes 
that results of epidemiological studies have been inconsistent and that smoking has not been 
determined to be a definitive risk factor in the development of NHL (Peach and Barnett 
2000). 
A Danish study has linked the use of tricyclic and tetracyclic antidepressants to NHL.  
However, more research is needed on this possible association (Dalton et al. 2000). 
Recent studies have also linked Hepatitis C virus infection with increased risk for NHL, 
particularly the subtype of Waldenstrom’s macroglobulinemia.  However, these studies 
focused on individuals within the Veteran’s Administration healthcare system, a limited 
group which does not reflect the general population (Giordano et al., 2007). 
Although NHL is associated with a number of risk factors, the causes of this disease remain 
unknown.  Most patients with NHL do not have any known risk factors (ACS 2006a). 
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